UCHL3 Data Analysis

HGNC Gene Name
ubiquitin C-terminal hydrolase L3
HGNC Gene Symbol
UCHL3
Identifiers
hgnc:12515 NCBIGene:7347 uniprot:P15374
Orthologs
mgi:1355274 rgd:1561196
INDRA Statements
deubiquitinations all statements
Pathway Commons
Search for UCHL3
Number of Papers
158 retrieved on 2023-02-19

DepMap Analysis

The Dependency Map (DepMap) is a genome-wide pooled CRISPR-Cas9 knockout proliferation screen conducted in more than 700 cancer cell lines spanning many different tumor lineages. Each cell line in the DepMap contains a unique barcode, and each gene knockout is assigned a “dependency score” on a per cell-line basis which quantifies the rate of CRISPR-Cas9 guide drop. It has been found that proteins with similar DepMap scores across cell lines, a phenomenon known as co-dependent genes, have closely related biological functions. This can include activity in the same or parallel pathways or membership in the same protein complex or the same pathway.

We identified the strongest seven co-dependent genes (“Symbol”) for DUBs and ran GO enrichment analysis. We used Biogrid, IntAct, and Pathway Commons PPIDs, and the NURSA protein-protein interaction databases (PPIDs) to determine whether co-dependent genes interact with one another. The “Evidence” column contains the PPIDs in which the interaction appears as well as whether there is support for the association by an INDRA statement. As another approach to identify potential interactors, we looked at proteomics data from the Broad Institute's Cancer Cell Line Encyclopedia (CCLE) for proteins whose expression across ~375 cell lines strongly correlated with the abundance of each DUB; it has previously been observed that proteins in the same complex are frequently significantly co-expressed. The correlations and associated p-values in the CCLE proteomics dataset are provided. And, we determined whether co-dependent genes yield similar transcriptomic signatures in the Broad Institute's Connectivity Map (CMap). A CMap score greater than 90 is considered significantly similar.

DepMap Correlations

Symbol Name DepMap Correlation Evidence CCLE Correlation CCLE Z-score CCLE p-value (adj) CCLE Significant CMAP Score CMAP Type
PPM1D protein phosphatase, Mg2+/Mn2+ dependent 1D 0.297 -0.15 -0.90 1.51e-01
MDM2 MDM2 proto-oncogene 0.266 Reactome (3) 0.01 -0.02 9.05e-01
COMMD6 COMM domain containing 6 0.259 Reactome (3) 0.47 2.52 4.06e-20
TP53BP1 tumor protein p53 binding protein 1 -0.253 Reactome (2) -0.42 -2.40 7.93e-16
TP53 tumor protein p53 -0.249 Reactome (3) 0.06 0.22 4.06e-01
KRTAP21-1 keratin associated protein 21-1 0.24
MDM4 MDM4 regulator of p53 0.231 Reactome (3)

Dependency GO Term Enrichment

Gene set enrichment analysis was done on the genes correlated with UCHL3using the terms from Gene Ontology and gene sets derived from the Gene Ontology Annotations database via MSigDB.

Using the biological processes and other Gene Ontology terms from well characterized DUBs as a positive control, several gene set enrichment analyses were considered. Threshold-less methods like GSEA had relatively poor results. Over-representation analysis with a threshold of of the top 7 highest absolute value Dependency Map correlations yielded the best results and is reported below.

GO Identifier GO Name GO Type p-value p-value (adj.) q-value
GO:0030330 DNA damage response, signal transduction by p53 class mediator Biological Process 1.37e-08 6.14e-06 1.63e-06
GO:0042770 signal transduction in response to DNA damage Biological Process 3.32e-08 1.49e-05 1.98e-06
GO:0031570 DNA integrity checkpoint Biological Process 6.85e-08 3.08e-05 2.72e-06
GO:0000075 cell cycle checkpoint Biological Process 2.41e-07 1.08e-04 7.16e-06
GO:0072331 signal transduction by p53 class mediator Biological Process 5.54e-07 2.49e-04 1.29e-05
GO:0002039 p53 binding Molecular Function 7.62e-07 3.42e-04 1.29e-05
GO:0071479 cellular response to ionizing radiation Biological Process 9.96e-07 4.47e-04 1.48e-05
GO:0072395 signal transduction involved in cell cycle checkpoint Biological Process 1.13e-06 5.07e-04 1.49e-05
GO:0071158 positive regulation of cell cycle arrest Biological Process 1.54e-06 6.92e-04 1.83e-05
GO:0044774 mitotic DNA integrity checkpoint Biological Process 3.44e-06 1.55e-03 3.51e-05
GO:0071156 regulation of cell cycle arrest Biological Process 3.54e-06 1.59e-03 3.51e-05
GO:0009314 response to radiation Biological Process 4.43e-06 1.99e-03 4.05e-05
GO:1902807 negative regulation of cell cycle G1/S phase transition Biological Process 6.19e-06 2.78e-03 5.26e-05
GO:0010212 response to ionizing radiation Biological Process 9.14e-06 4.10e-03 7.25e-05
GO:0007093 mitotic cell cycle checkpoint Biological Process 1.27e-05 5.69e-03 9.42e-05
GO:1901796 regulation of signal transduction by p53 class mediator Biological Process 1.62e-05 7.26e-03 1.13e-04
GO:0046827 positive regulation of protein export from nucleus Biological Process 1.75e-05 7.84e-03 1.15e-04
GO:0071478 cellular response to radiation Biological Process 1.93e-05 8.68e-03 1.21e-04
GO:0071157 negative regulation of cell cycle arrest Biological Process 2.10e-05 9.44e-03 1.25e-04
GO:1902806 regulation of cell cycle G1/S phase transition Biological Process 2.25e-05 1.01e-02 1.28e-04
GO:0071480 cellular response to gamma radiation Biological Process 3.37e-05 1.51e-02 1.82e-04
GO:0071453 cellular response to oxygen levels Biological Process 3.60e-05 1.62e-02 1.86e-04
GO:0007050 cell cycle arrest Biological Process 4.08e-05 1.83e-02 1.96e-04
GO:0097718 disordered domain specific binding Molecular Function 4.12e-05 1.85e-02 1.96e-04
GO:1901988 negative regulation of cell cycle phase transition Biological Process 5.22e-05 2.34e-02 2.33e-04
GO:0031668 cellular response to extracellular stimulus Biological Process 5.28e-05 2.37e-02 2.33e-04
GO:0046825 regulation of protein export from nucleus Biological Process 6.47e-05 2.90e-02 2.75e-04
GO:0044843 cell cycle G1/S phase transition Biological Process 7.04e-05 3.16e-02 2.87e-04
GO:0090068 positive regulation of cell cycle process Biological Process 7.33e-05 3.29e-02 2.87e-04
GO:0070646 protein modification by small protein removal Biological Process 7.48e-05 3.36e-02 2.87e-04
GO:0071214 cellular response to abiotic stimulus Biological Process 9.32e-05 4.19e-02 3.47e-04
GO:0071496 cellular response to external stimulus Biological Process 1.05e-04 4.71e-02 3.67e-04
GO:0045930 negative regulation of mitotic cell cycle Biological Process 1.05e-04 4.71e-02 3.67e-04

Transcriptomics

The following table shows the significantly differentially expressed genes after knocking out UCHL3 using CRISPR-Cas9.

Knockout Differential Expression

Symbol Name log2-fold-change p-value p-value (adj.)
UCHL3 ubiquitin C-terminal hydrolase L3 -1.06e+00 6.55e-13 3.53e-09
SMARCA5 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 8.69e-01 1.44e-07 2.78e-04
TPM4 tropomyosin 4 4.71e-01 1.55e-07 2.78e-04
PTBP1 polypyrimidine tract binding protein 1 9.60e-01 3.08e-07 4.15e-04
YBX1 Y-box binding protein 1 5.89e-01 5.02e-07 5.40e-04
HNRNPAB heterogeneous nuclear ribonucleoprotein A/B 6.66e-01 6.65e-07 5.96e-04
CEP55 centrosomal protein 55 9.11e-01 1.31e-06 1.01e-03
SUPT6H SPT6 homolog, histone chaperone and transcription elongation factor 7.42e-01 1.50e-06 1.01e-03
BAP1 BRCA1 associated protein 1 -6.93e-01 3.14e-06 1.86e-03
CENPF centromere protein F 4.71e-01 3.46e-06 1.86e-03
CKAP5 cytoskeleton associated protein 5 5.94e-01 5.46e-06 2.67e-03
TCHP trichoplein keratin filament binding 5.67e-01 9.25e-06 4.15e-03
IQGAP1 IQ motif containing GTPase activating protein 1 6.79e-01 1.03e-05 4.27e-03
SPTBN1 spectrin beta, non-erythrocytic 1 4.96e-01 1.33e-05 5.10e-03
ANP32A acidic nuclear phosphoprotein 32 family member A 7.54e-01 1.45e-05 5.21e-03
TPM3 tropomyosin 3 4.40e-01 2.18e-05 7.32e-03
SHCBP1 SHC binding and spindle associated 1 8.39e-01 2.45e-05 7.75e-03
SENP7 SUMO specific peptidase 7 -6.76e-01 2.99e-05 8.48e-03
TAF15 TATA-box binding protein associated factor 15 7.10e-01 2.92e-05 8.48e-03
HDGF heparin binding growth factor 5.45e-01 3.93e-05 1.06e-02
ARHGAP35 Rho GTPase activating protein 35 6.99e-01 5.13e-05 1.12e-02
EZR ezrin 4.01e-01 5.20e-05 1.12e-02
GOLGB1 golgin B1 6.63e-01 5.00e-05 1.12e-02
NABP1 nucleic acid binding protein 1 -3.61e-01 4.58e-05 1.12e-02
PJA2 praja ring finger ubiquitin ligase 2 7.37e-01 5.63e-05 1.17e-02
BEX3 brain expressed X-linked 3 -2.67e-01 6.08e-05 1.21e-02
CD59 CD59 molecule (CD59 blood group) -3.51e-01 7.20e-05 1.36e-02
IGFBP4 insulin like growth factor binding protein 4 -3.32e-01 7.31e-05 1.36e-02
EPB41L2 erythrocyte membrane protein band 4.1 like 2 7.05e-01 8.03e-05 1.44e-02
EIF3C eukaryotic translation initiation factor 3 subunit C 5.05e-01 9.17e-05 1.59e-02
YIPF4 Yip1 domain family member 4 4.48e-01 1.30e-04 2.18e-02
MSN moesin 5.15e-01 1.47e-04 2.40e-02
DENR density regulated re-initiation and release factor 4.13e-01 1.61e-04 2.48e-02
MIA3 MIA SH3 domain ER export factor 3 5.82e-01 1.61e-04 2.48e-02
FTH1 ferritin heavy chain 1 4.58e-01 1.81e-04 2.51e-02
NOL7 nucleolar protein 7 3.94e-01 1.73e-04 2.51e-02
SMC1A structural maintenance of chromosomes 1A 4.79e-01 1.82e-04 2.51e-02
TOP1 DNA topoisomerase I 4.86e-01 1.81e-04 2.51e-02
C15orf48 chromosome 15 open reading frame 48 -5.71e-01 2.04e-04 2.63e-02
ENAH ENAH actin regulator 6.82e-01 2.09e-04 2.63e-02
HS3ST1 heparan sulfate-glucosamine 3-sulfotransferase 1 -3.33e-01 2.15e-04 2.63e-02
NDUFB5 NADH:ubiquinone oxidoreductase subunit B5 -4.52e-01 2.15e-04 2.63e-02
PPM1G protein phosphatase, Mg2+/Mn2+ dependent 1G 4.00e-01 2.06e-04 2.63e-02
HNRNPA2B1 heterogeneous nuclear ribonucleoprotein A2/B1 2.46e-01 2.24e-04 2.68e-02
PDAP1 PDGFA associated protein 1 4.71e-01 2.46e-04 2.77e-02
SRP72 signal recognition particle 72 4.40e-01 2.38e-04 2.77e-02
WDR3 WD repeat domain 3 6.27e-01 2.47e-04 2.77e-02
AKAP12 A-kinase anchoring protein 12 6.44e-01 2.60e-04 2.86e-02
EIF4B eukaryotic translation initiation factor 4B 5.35e-01 2.99e-04 3.22e-02
CAB39 calcium binding protein 39 6.02e-01 3.20e-04 3.31e-02
NCL nucleolin 3.99e-01 3.19e-04 3.31e-02
CEP250 centrosomal protein 250 4.95e-01 3.28e-04 3.33e-02
MTCO2P2 MT-CO2 pseudogene 2 -5.03e-01 3.48e-04 3.37e-02
MYH9 myosin heavy chain 9 4.47e-01 3.55e-04 3.37e-02
EPRS1 glutamyl-prolyl-tRNA synthetase 1 -4.94e-01 3.45e-04 3.37e-02
RBSN rabenosyn, RAB effector 6.81e-01 3.57e-04 3.37e-02
MT-CO2 mitochondrially encoded cytochrome c oxidase II -2.23e-01 3.84e-04 3.57e-02
DSP desmoplakin 6.32e-01 4.24e-04 3.82e-02
LRRC69 leucine rich repeat containing 69 1.91e-01 4.26e-04 3.82e-02
NRDC nardilysin convertase 5.20e-01 4.53e-04 4.00e-02
GBP1P1 guanylate binding protein 1 pseudogene 1 -5.14e-01 5.07e-04 4.36e-02
HNRNPD heterogeneous nuclear ribonucleoprotein D 4.64e-01 5.11e-04 4.36e-02
NIPBL NIPBL cohesin loading factor 6.29e-01 5.41e-04 4.48e-02
SSR2 signal sequence receptor subunit 2 -2.97e-01 5.39e-04 4.48e-02
AHNAK AHNAK nucleoprotein 5.86e-01 5.71e-04 4.59e-02
ZMYND8 zinc finger MYND-type containing 8 5.09e-01 5.67e-04 4.59e-02
BNIP3 BCL2 interacting protein 3 -4.10e-01 6.90e-04 4.84e-02
CAPN7 calpain 7 7.19e-01 6.84e-04 4.84e-02
FCF1 FCF1 rRNA-processing protein 5.67e-01 6.47e-04 4.84e-02
IFI16 interferon gamma inducible protein 16 5.22e-01 6.56e-04 4.84e-02
NDC1 NDC1 transmembrane nucleoporin 6.03e-01 6.92e-04 4.84e-02
NOP14 NOP14 nucleolar protein 5.90e-01 6.73e-04 4.84e-02
R3HDM1 R3H domain containing 1 6.15e-01 6.36e-04 4.84e-02
SMARCC1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1 5.67e-01 6.86e-04 4.84e-02
SMIM15 small integral membrane protein 15 5.55e-01 6.38e-04 4.84e-02
SYAP1 synapse associated protein 1 4.16e-01 6.54e-04 4.84e-02
CHMP4B charged multivesicular body protein 4B 6.76e-01 7.16e-04 4.94e-02

Gene Set Enrichment Analysis

The GSEA method was applied for all genes whose knockout resulted in at least 20 significantly differentially expressed genes.

ID Name p-value p-value (adj.) log2 Error ES NES
msig:M5893 HALLMARK_MITOTIC_SPINDLE 2.11e-09 3.76e-06 7.75e-01 5.20e-01 2.17e+00
go:0008092 cytoskeletal protein binding 1.28e-09 3.76e-06 7.88e-01 4.09e-01 1.90e+00
go:0007010 cytoskeleton organization 3.19e-09 3.80e-06 7.75e-01 3.75e-01 1.78e+00
go:0019904 protein domain specific binding 5.14e-08 4.58e-05 7.20e-01 4.07e-01 1.86e+00
go:0030554 adenyl nucleotide binding 2.42e-07 1.73e-04 6.75e-01 3.44e-01 1.66e+00
go:0050839 cell adhesion molecule binding 3.12e-07 1.86e-04 6.75e-01 4.02e-01 1.83e+00
go:0032553 ribonucleotide binding 5.51e-07 2.81e-04 6.59e-01 3.23e-01 1.57e+00
go:0042393 histone binding 7.30e-07 3.21e-04 6.59e-01 5.04e-01 2.04e+00
go:0003682 chromatin binding 9.91e-07 3.21e-04 6.44e-01 4.02e-01 1.80e+00
go:0015630 microtubule cytoskeleton 9.33e-07 3.21e-04 6.59e-01 3.39e-01 1.62e+00
go:0006091 generation of precursor metabolites and energy 8.66e-07 3.21e-04 6.59e-01 -3.29e-01 -1.75e+00
go:0044429 1.14e-06 3.39e-04 6.44e-01 -2.65e-01 -1.51e+00
go:0044430 1.55e-06 4.24e-04 6.44e-01 3.25e-01 1.57e+00
go:0010628 positive regulation of gene expression 1.95e-06 4.63e-04 6.27e-01 3.19e-01 1.55e+00
go:0045296 cadherin binding 2.31e-06 5.15e-04 6.27e-01 4.04e-01 1.80e+00
go:0008144 drug binding 2.88e-06 5.70e-04 6.27e-01 3.19e-01 1.54e+00
go:0051276 chromosome organization 3.62e-06 6.46e-04 6.27e-01 3.24e-01 1.56e+00
go:0098590 plasma membrane region 5.13e-06 8.71e-04 6.11e-01 3.87e-01 1.74e+00
go:0033043 regulation of organelle organization 5.78e-06 8.97e-04 6.11e-01 3.20e-01 1.54e+00
go:0015631 tubulin binding 5.61e-06 8.97e-04 6.11e-01 4.45e-01 1.87e+00
go:0044877 protein-containing complex binding 6.97e-06 9.56e-04 6.11e-01 3.40e-01 1.61e+00
go:0098800 inner mitochondrial membrane protein complex 6.97e-06 9.56e-04 6.11e-01 -4.09e-01 -1.90e+00
go:0030029 actin filament-based process 6.67e-06 9.56e-04 6.11e-01 3.77e-01 1.69e+00
go:0000226 microtubule cytoskeleton organization 7.67e-06 9.77e-04 5.93e-01 3.88e-01 1.74e+00
go:0003779 actin binding 7.55e-06 9.77e-04 6.11e-01 4.31e-01 1.84e+00
go:0019900 kinase binding 8.91e-06 1.10e-03 5.93e-01 3.65e-01 1.67e+00
go:0099080 supramolecular complex 9.72e-06 1.12e-03 5.93e-01 3.76e-01 1.72e+00
go:0007017 microtubule-based process 9.58e-06 1.12e-03 5.93e-01 3.60e-01 1.66e+00
go:0005815 microtubule organizing center 1.01e-05 1.13e-03 5.93e-01 3.57e-01 1.65e+00
go:0009891 positive regulation of biosynthetic process 1.13e-05 1.22e-03 5.93e-01 3.08e-01 1.49e+00
go:0051493 regulation of cytoskeleton organization 1.26e-05 1.32e-03 5.93e-01 3.99e-01 1.77e+00
go:0022900 electron transport chain 1.31e-05 1.33e-03 5.93e-01 -3.76e-01 -1.79e+00
go:0022402 cell cycle process 1.66e-05 1.64e-03 5.76e-01 3.07e-01 1.49e+00
go:0030030 cell projection organization 1.83e-05 1.76e-03 5.76e-01 3.31e-01 1.57e+00
go:0097435 supramolecular fiber organization 1.94e-05 1.82e-03 5.76e-01 3.82e-01 1.71e+00
go:0032990 cell part morphogenesis 2.25e-05 2.05e-03 5.76e-01 4.10e-01 1.79e+00
go:0030182 neuron differentiation 2.50e-05 2.12e-03 5.76e-01 3.49e-01 1.62e+00
go:0031399 regulation of protein modification process 2.49e-05 2.12e-03 5.76e-01 3.11e-01 1.51e+00
go:0048589 developmental growth 2.50e-05 2.12e-03 5.76e-01 3.94e-01 1.74e+00
go:0022008 neurogenesis 3.04e-05 2.50e-03 5.76e-01 3.30e-01 1.55e+00
go:0032989 cellular component morphogenesis 3.09e-05 2.50e-03 5.57e-01 3.52e-01 1.62e+00
go:0006119 oxidative phosphorylation 3.41e-05 2.61e-03 5.57e-01 -3.77e-01 -1.75e+00
go:0019866 organelle inner membrane 3.44e-05 2.61e-03 5.57e-01 -2.81e-01 -1.52e+00
go:0016887 ATPase activity 3.57e-05 2.62e-03 5.57e-01 3.94e-01 1.74e+00
go:0003690 double-stranded DNA binding 3.60e-05 2.62e-03 5.57e-01 3.56e-01 1.63e+00
go:0009890 negative regulation of biosynthetic process 3.79e-05 2.70e-03 5.57e-01 3.18e-01 1.53e+00
go:0071103 DNA conformation change 3.99e-05 2.74e-03 5.57e-01 4.16e-01 1.77e+00
reactome:R-HSA-1428517 The citric acid (TCA) cycle and respiratory electron transport 3.96e-05 2.74e-03 5.57e-01 -3.58e-01 -1.72e+00
go:0044455 4.46e-05 2.84e-03 5.57e-01 -3.39e-01 -1.69e+00
go:0099568 cytoplasmic region 4.45e-05 2.84e-03 5.57e-01 4.03e-01 1.76e+00
go:0050684 regulation of mRNA processing 4.56e-05 2.85e-03 5.57e-01 4.59e-01 1.86e+00
go:0007051 spindle organization 5.10e-05 3.08e-03 5.57e-01 4.55e-01 1.84e+00
go:0004386 helicase activity 5.03e-05 3.08e-03 5.57e-01 4.73e-01 1.87e+00
go:0005740 mitochondrial envelope 5.70e-05 3.39e-03 5.57e-01 -2.64e-01 -1.45e+00
go:0000122 negative regulation of transcription by RNA polymerase II 5.94e-05 3.48e-03 5.57e-01 3.59e-01 1.64e+00
go:0005694 chromosome 6.14e-05 3.53e-03 5.38e-01 3.12e-01 1.50e+00
go:0033044 regulation of chromosome organization 6.97e-05 3.71e-03 5.38e-01 3.87e-01 1.71e+00
go:0022904 respiratory electron transport chain 6.75e-05 3.71e-03 5.38e-01 -3.99e-01 -1.82e+00
go:0016604 nuclear body 6.88e-05 3.71e-03 5.38e-01 3.29e-01 1.54e+00
go:0010564 regulation of cell cycle process 6.88e-05 3.71e-03 5.38e-01 3.24e-01 1.52e+00
go:0008094 DNA-dependent ATPase activity 6.69e-05 3.71e-03 5.38e-01 5.32e-01 1.94e+00
go:0008017 microtubule binding 7.40e-05 3.88e-03 5.38e-01 4.52e-01 1.83e+00
go:0061061 muscle structure development 8.22e-05 4.19e-03 5.38e-01 3.87e-01 1.70e+00
go:0015980 energy derivation by oxidation of organic compounds 8.18e-05 4.19e-03 5.38e-01 -3.30e-01 -1.64e+00
go:0051174 regulation of phosphorus metabolic process 9.24e-05 4.58e-03 5.38e-01 3.08e-01 1.48e+00
go:0043565 sequence-specific DNA binding 9.19e-05 4.58e-03 5.38e-01 3.51e-01 1.61e+00
go:0030496 midbody 9.49e-05 4.64e-03 5.38e-01 4.39e-01 1.80e+00
go:0030054 cell junction 1.09e-04 5.23e-03 5.38e-01 3.18e-01 1.51e+00
go:0007507 heart development 1.18e-04 5.59e-03 5.38e-01 3.97e-01 1.72e+00
go:0051056 regulation of small GTPase mediated signal transduction 1.27e-04 5.84e-03 5.19e-01 4.58e-01 1.84e+00
go:0005819 spindle 1.25e-04 5.84e-03 5.19e-01 3.82e-01 1.69e+00
go:0045944 positive regulation of transcription by RNA polymerase II 1.28e-04 5.84e-03 5.19e-01 3.31e-01 1.54e+00
go:0010562 positive regulation of phosphorus metabolic process 1.39e-04 6.28e-03 5.19e-01 3.37e-01 1.56e+00
go:0043583 ear development 1.43e-04 6.29e-03 5.19e-01 5.55e-01 1.96e+00
go:0098803 respiratory chain complex 1.53e-04 6.65e-03 5.19e-01 -4.22e-01 -1.85e+00
go:0045333 cellular respiration 1.59e-04 6.73e-03 5.19e-01 -3.53e-01 -1.70e+00
go:0004672 protein kinase activity 1.57e-04 6.73e-03 5.19e-01 3.88e-01 1.70e+00
go:0030048 actin filament-based movement 1.71e-04 7.19e-03 5.19e-01 5.71e-01 1.96e+00
go:0034728 nucleosome organization 1.77e-04 7.26e-03 5.19e-01 4.85e-01 1.87e+00
go:0005813 centrosome 1.77e-04 7.26e-03 5.19e-01 3.51e-01 1.58e+00
go:0000910 cytokinesis 1.80e-04 7.28e-03 5.19e-01 4.62e-01 1.83e+00
go:0099513 polymeric cytoskeletal fiber 1.84e-04 7.37e-03 5.19e-01 3.55e-01 1.60e+00
go:0044093 positive regulation of molecular function 1.91e-04 7.49e-03 5.19e-01 2.99e-01 1.45e+00
go:0005759 mitochondrial matrix 1.96e-04 7.50e-03 5.19e-01 -2.82e-01 -1.50e+00
go:0051640 organelle localization 1.95e-04 7.50e-03 5.19e-01 3.41e-01 1.56e+00
go:0061028 establishment of endothelial barrier 2.11e-04 7.82e-03 5.19e-01 6.99e-01 2.01e+00
go:0005938 cell cortex 2.11e-04 7.82e-03 5.19e-01 4.19e-01 1.74e+00
go:0070997 neuron death 2.16e-04 7.87e-03 5.19e-01 4.07e-01 1.70e+00
go:0070469 respirasome 2.24e-04 8.07e-03 5.19e-01 -3.99e-01 -1.78e+00
go:0048666 neuron development 2.74e-04 9.78e-03 4.98e-01 3.38e-01 1.55e+00
go:0048667 cell morphogenesis involved in neuron differentiation 2.81e-04 9.87e-03 4.98e-01 3.96e-01 1.68e+00
go:0008134 transcription factor binding 2.82e-04 9.87e-03 4.98e-01 3.41e-01 1.55e+00
reactome:R-HSA-73884 Base Excision Repair 2.93e-04 1.01e-02 4.98e-01 -5.21e-01 -1.97e+00
go:0031346 positive regulation of cell projection organization 2.94e-04 1.01e-02 4.98e-01 4.12e-01 1.71e+00
go:0070603 SWI/SNF superfamily-type complex 3.12e-04 1.06e-02 4.98e-01 5.30e-01 1.89e+00
go:0045595 regulation of cell differentiation 3.23e-04 1.08e-02 4.98e-01 3.01e-01 1.44e+00
go:0051656 establishment of organelle localization 3.20e-04 1.08e-02 4.98e-01 3.61e-01 1.60e+00
go:0045664 regulation of neuron differentiation 3.41e-04 1.09e-02 4.98e-01 3.88e-01 1.68e+00
go:0042773 ATP synthesis coupled electron transport 3.39e-04 1.09e-02 4.98e-01 -3.93e-01 -1.75e+00
go:0000904 cell morphogenesis involved in differentiation 3.36e-04 1.09e-02 4.98e-01 3.65e-01 1.62e+00
go:0003700 DNA-binding transcription factor activity 3.41e-04 1.09e-02 4.98e-01 3.19e-01 1.48e+00
go:0006325 chromatin organization 3.47e-04 1.09e-02 4.98e-01 3.23e-01 1.50e+00
go:0000785 chromatin 3.44e-04 1.09e-02 4.98e-01 3.40e-01 1.53e+00
go:0040011 locomotion 3.49e-04 1.09e-02 4.98e-01 3.00e-01 1.43e+00
go:0016607 nuclear speck 3.75e-04 1.15e-02 4.98e-01 3.45e-01 1.54e+00
reactome:R-HSA-75153 Apoptotic execution phase 3.75e-04 1.15e-02 4.98e-01 5.90e-01 1.94e+00
go:0007163 establishment or maintenance of cell polarity 3.92e-04 1.16e-02 4.98e-01 4.50e-01 1.78e+00
reactome:R-HSA-5689603 UCH proteinases 3.93e-04 1.16e-02 4.98e-01 -4.15e-01 -1.81e+00
go:0006468 protein phosphorylation 3.89e-04 1.16e-02 4.98e-01 2.89e-01 1.40e+00
msig:M7272 KEGG_PARKINSONS_DISEASE 3.82e-04 1.16e-02 4.98e-01 -3.74e-01 -1.72e+00
reactome:R-HSA-163200 Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. 4.11e-04 1.20e-02 4.98e-01 -3.60e-01 -1.67e+00
go:0099177 regulation of trans-synaptic signaling 4.14e-04 1.20e-02 4.98e-01 4.47e-01 1.76e+00
go:0060284 regulation of cell development 4.22e-04 1.20e-02 4.98e-01 3.41e-01 1.54e+00
msig:M5934 HALLMARK_XENOBIOTIC_METABOLISM 4.25e-04 1.20e-02 4.98e-01 -3.96e-01 -1.76e+00
go:1990266 neutrophil migration 4.23e-04 1.20e-02 4.98e-01 -6.71e-01 -2.07e+00
go:0097060 synaptic membrane 4.48e-04 1.25e-02 4.98e-01 5.00e-01 1.84e+00
go:0051018 protein kinase A binding 4.47e-04 1.25e-02 4.98e-01 7.07e-01 1.98e+00
go:0051960 regulation of nervous system development 4.86e-04 1.34e-02 4.98e-01 3.48e-01 1.56e+00
go:0006338 chromatin remodeling 4.96e-04 1.36e-02 4.77e-01 4.31e-01 1.73e+00
reactome:R-HSA-1500931 Cell-Cell communication 5.15e-04 1.39e-02 4.77e-01 5.41e-01 1.88e+00
go:0035064 methylated histone binding 5.15e-04 1.39e-02 4.77e-01 6.09e-01 1.95e+00
go:0003725 double-stranded RNA binding 5.24e-04 1.40e-02 4.77e-01 5.22e-01 1.86e+00
go:0070161 anchoring junction 5.28e-04 1.40e-02 4.77e-01 3.28e-01 1.51e+00
go:0016071 mRNA metabolic process 5.33e-04 1.40e-02 4.77e-01 3.17e-01 1.48e+00
go:0051983 regulation of chromosome segregation 5.36e-04 1.40e-02 4.77e-01 4.57e-01 1.78e+00
go:0005884 actin filament 5.89e-04 1.53e-02 4.77e-01 5.63e-01 1.87e+00
reactome:R-HSA-5696397 Gap-filling DNA repair synthesis and ligation in GG-NER 6.42e-04 1.66e-02 4.77e-01 -6.34e-01 -2.01e+00
go:0051347 positive regulation of transferase activity 6.58e-04 1.69e-02 4.77e-01 3.49e-01 1.57e+00
go:0046847 filopodium assembly 6.64e-04 1.69e-02 4.77e-01 6.67e-01 1.95e+00
go:0044282 small molecule catabolic process 6.70e-04 1.70e-02 4.77e-01 -3.32e-01 -1.54e+00
go:0044087 regulation of cellular component biogenesis 6.86e-04 1.72e-02 4.77e-01 3.15e-01 1.46e+00
go:0005516 calmodulin binding 6.97e-04 1.74e-02 4.77e-01 5.06e-01 1.84e+00
reactome:R-HSA-611105 Respiratory electron transport 7.20e-04 1.78e-02 4.77e-01 -3.80e-01 -1.70e+00
go:0031252 cell leading edge 7.31e-04 1.80e-02 4.77e-01 3.76e-01 1.60e+00
go:0007423 sensory organ development 7.40e-04 1.81e-02 4.77e-01 4.03e-01 1.67e+00
go:0001885 endothelial cell development 7.67e-04 1.86e-02 4.77e-01 6.25e-01 1.95e+00
go:0072359 circulatory system development 7.80e-04 1.88e-02 4.77e-01 3.25e-01 1.49e+00
go:0098813 nuclear chromosome segregation 8.03e-04 1.92e-02 4.77e-01 3.74e-01 1.59e+00
go:0090068 positive regulation of cell cycle process 8.15e-04 1.92e-02 4.77e-01 3.79e-01 1.61e+00
go:0032886 regulation of microtubule-based process 8.12e-04 1.92e-02 4.77e-01 4.14e-01 1.67e+00
go:0090224 regulation of spindle organization 8.32e-04 1.95e-02 4.77e-01 6.08e-01 1.91e+00
go:0080135 regulation of cellular response to stress 8.77e-04 2.03e-02 4.77e-01 3.24e-01 1.49e+00
go:0031401 positive regulation of protein modification process 9.40e-04 2.14e-02 4.77e-01 3.07e-01 1.44e+00
reactome:R-HSA-157579 Telomere Maintenance 9.50e-04 2.14e-02 4.77e-01 -5.18e-01 -1.91e+00
go:0030055 cell-substrate junction 9.62e-04 2.16e-02 4.77e-01 3.27e-01 1.47e+00
go:0045202 synapse 9.88e-04 2.20e-02 4.55e-01 3.22e-01 1.49e+00
go:0022610 biological adhesion 1.01e-03 2.24e-02 4.55e-01 3.08e-01 1.44e+00
go:0048167 regulation of synaptic plasticity 1.02e-03 2.25e-02 4.55e-01 5.49e-01 1.83e+00
go:0044242 cellular lipid catabolic process 1.03e-03 2.26e-02 4.55e-01 -4.12e-01 -1.73e+00
go:0043085 positive regulation of catalytic activity 1.04e-03 2.26e-02 4.55e-01 2.94e-01 1.40e+00
go:0050918 positive chemotaxis 1.05e-03 2.26e-02 4.55e-01 -6.47e-01 -1.99e+00
go:0051726 regulation of cell cycle 1.07e-03 2.29e-02 4.55e-01 2.88e-01 1.39e+00
go:0007059 chromosome segregation 1.07e-03 2.29e-02 4.55e-01 3.60e-01 1.58e+00
go:0051236 establishment of RNA localization 1.08e-03 2.29e-02 4.55e-01 3.81e-01 1.61e+00
go:0032506 cytokinetic process 1.13e-03 2.39e-02 4.55e-01 5.82e-01 1.84e+00
go:0051233 spindle midzone 1.16e-03 2.41e-02 4.55e-01 6.20e-01 1.88e+00
go:0005911 cell-cell junction 1.15e-03 2.41e-02 4.55e-01 3.84e-01 1.63e+00
go:0016052 carbohydrate catabolic process 1.21e-03 2.50e-02 4.55e-01 -3.89e-01 -1.70e+00
go:0051338 regulation of transferase activity 1.24e-03 2.55e-02 4.55e-01 3.07e-01 1.43e+00
go:0032970 regulation of actin filament-based process 1.25e-03 2.57e-02 4.55e-01 3.78e-01 1.60e+00
go:0000922 spindle pole 1.27e-03 2.59e-02 4.55e-01 4.20e-01 1.68e+00
go:1901215 negative regulation of neuron death 1.29e-03 2.61e-02 4.55e-01 4.48e-01 1.73e+00
go:0000278 mitotic cell cycle 1.31e-03 2.62e-02 4.55e-01 2.93e-01 1.40e+00
go:0061564 axon development 1.31e-03 2.62e-02 4.55e-01 3.95e-01 1.65e+00
go:0044309 neuron spine 1.34e-03 2.67e-02 4.55e-01 4.97e-01 1.79e+00
go:0044380 protein localization to cytoskeleton 1.39e-03 2.76e-02 4.55e-01 6.19e-01 1.89e+00
go:1904949 ATPase complex 1.43e-03 2.80e-02 4.55e-01 4.80e-01 1.75e+00
go:0010975 regulation of neuron projection development 1.44e-03 2.80e-02 4.55e-01 3.85e-01 1.61e+00
go:0006275 regulation of DNA replication 1.43e-03 2.80e-02 4.55e-01 4.81e-01 1.76e+00
go:0097485 neuron projection guidance 1.46e-03 2.81e-02 4.55e-01 4.79e-01 1.75e+00
go:0098796 membrane protein complex 1.46e-03 2.81e-02 4.55e-01 -2.40e-01 -1.33e+00
reactome:R-HSA-8941858 Regulation of RUNX3 expression and activity 1.47e-03 2.81e-02 4.55e-01 -4.57e-01 -1.80e+00
go:0048515 spermatid differentiation 1.49e-03 2.83e-02 4.55e-01 5.80e-01 1.85e+00
go:0008194 UDP-glycosyltransferase activity 1.49e-03 2.83e-02 4.55e-01 -5.34e-01 -1.89e+00
go:0031491 nucleosome binding 1.52e-03 2.86e-02 4.55e-01 4.95e-01 1.77e+00
go:0015629 actin cytoskeleton 1.53e-03 2.87e-02 4.55e-01 3.50e-01 1.54e+00
go:0004674 protein serine/threonine kinase activity 1.58e-03 2.94e-02 4.55e-01 3.75e-01 1.59e+00
go:0000018 regulation of DNA recombination 1.61e-03 2.97e-02 4.55e-01 5.15e-01 1.78e+00
go:0016817 hydrolase activity, acting on acid anhydrides 1.60e-03 2.97e-02 4.55e-01 3.03e-01 1.42e+00
go:0045787 positive regulation of cell cycle 1.64e-03 3.01e-02 4.55e-01 3.47e-01 1.52e+00
go:0060148 positive regulation of posttranscriptional gene silencing 1.68e-03 3.08e-02 4.55e-01 6.68e-01 1.81e+00
go:1902850 microtubule cytoskeleton organization involved in mitosis 1.72e-03 3.14e-02 4.55e-01 4.34e-01 1.69e+00
go:0035264 multicellular organism growth 1.77e-03 3.20e-02 4.55e-01 5.00e-01 1.78e+00
go:0006297 nucleotide-excision repair, DNA gap filling 1.79e-03 3.22e-02 4.55e-01 -6.34e-01 -1.95e+00
msig:M19540 KEGG_OXIDATIVE_PHOSPHORYLATION 1.87e-03 3.33e-02 4.55e-01 -3.43e-01 -1.59e+00
go:0005739 mitochondrion 1.86e-03 3.33e-02 4.55e-01 -2.12e-01 -1.22e+00
go:0007169 transmembrane receptor protein tyrosine kinase signaling pathway 1.89e-03 3.35e-02 4.55e-01 3.25e-01 1.46e+00
go:0030010 establishment of cell polarity 1.96e-03 3.40e-02 4.32e-01 4.83e-01 1.76e+00
go:0045211 postsynaptic membrane 1.95e-03 3.40e-02 4.55e-01 5.31e-01 1.78e+00
go:0051962 positive regulation of nervous system development 1.95e-03 3.40e-02 4.55e-01 3.62e-01 1.54e+00
go:1990752 microtubule end 2.00e-03 3.41e-02 4.32e-01 6.69e-01 1.87e+00
go:0006403 RNA localization 1.98e-03 3.41e-02 4.32e-01 3.66e-01 1.59e+00
go:0042471 ear morphogenesis 1.97e-03 3.41e-02 4.32e-01 6.24e-01 1.89e+00
go:0046578 regulation of Ras protein signal transduction 1.99e-03 3.41e-02 4.32e-01 4.60e-01 1.74e+00
go:0051052 regulation of DNA metabolic process 2.01e-03 3.41e-02 4.32e-01 3.66e-01 1.55e+00
msig:M5901 HALLMARK_G2M_CHECKPOINT 2.23e-03 3.72e-02 4.32e-01 3.61e-01 1.55e+00
go:0051402 neuron apoptotic process 2.23e-03 3.72e-02 4.32e-01 4.11e-01 1.64e+00
go:0090066 regulation of anatomical structure size 2.21e-03 3.72e-02 4.32e-01 3.64e-01 1.56e+00
msig:M18306 KEGG_REGULATION_OF_ACTIN_CYTOSKELETON 2.26e-03 3.75e-02 4.32e-01 4.16e-01 1.65e+00
go:0031344 regulation of cell projection organization 2.35e-03 3.86e-02 4.32e-01 3.47e-01 1.53e+00
go:0040007 growth 2.42e-03 3.96e-02 4.32e-01 3.11e-01 1.44e+00
go:1902531 regulation of intracellular signal transduction 2.45e-03 3.97e-02 4.32e-01 2.76e-01 1.33e+00
msig:M9809 KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION 2.46e-03 3.97e-02 4.32e-01 -4.92e-01 -1.81e+00
go:0003006 developmental process involved in reproduction 2.46e-03 3.97e-02 4.32e-01 3.42e-01 1.50e+00
go:0016042 lipid catabolic process 2.48e-03 3.98e-02 4.32e-01 -3.60e-01 -1.59e+00
go:0071407 cellular response to organic cyclic compound 2.56e-03 4.10e-02 4.32e-01 3.39e-01 1.49e+00
go:0030865 cortical cytoskeleton organization 2.61e-03 4.15e-02 4.32e-01 5.95e-01 1.81e+00
go:2000779 regulation of double-strand break repair 2.65e-03 4.16e-02 4.32e-01 5.43e-01 1.79e+00
go:0008088 axo-dendritic transport 2.65e-03 4.16e-02 4.32e-01 5.37e-01 1.75e+00
reactome:R-HSA-5619115 Disorders of transmembrane transporters 2.64e-03 4.16e-02 4.32e-01 -3.53e-01 -1.57e+00
go:0006405 RNA export from nucleus 2.66e-03 4.16e-02 4.32e-01 3.85e-01 1.58e+00
go:0060324 face development 2.81e-03 4.38e-02 4.32e-01 6.30e-01 1.84e+00
go:0016757 transferase activity, transferring glycosyl groups 2.85e-03 4.42e-02 4.32e-01 -3.74e-01 -1.63e+00
go:1901224 positive regulation of NIK/NF-kappaB signaling 2.91e-03 4.49e-02 4.32e-01 5.77e-01 1.82e+00
go:0043292 contractile fiber 2.94e-03 4.52e-02 4.32e-01 4.32e-01 1.66e+00
go:0042391 regulation of membrane potential 2.96e-03 4.53e-02 4.32e-01 4.08e-01 1.63e+00
go:0140030 modification-dependent protein binding 2.99e-03 4.54e-02 4.32e-01 4.52e-01 1.71e+00
go:0043547 positive regulation of GTPase activity 2.98e-03 4.54e-02 4.32e-01 3.86e-01 1.59e+00
msig:M5936 HALLMARK_OXIDATIVE_PHOSPHORYLATION 3.01e-03 4.55e-02 4.32e-01 -2.87e-01 -1.43e+00
go:0010976 positive regulation of neuron projection development 3.09e-03 4.66e-02 4.32e-01 4.31e-01 1.70e+00
reactome:R-HSA-70268 Pyruvate metabolism 3.16e-03 4.74e-02 4.32e-01 -6.17e-01 -1.87e+00
go:0051247 positive regulation of protein metabolic process 3.21e-03 4.77e-02 4.32e-01 2.78e-01 1.34e+00
go:0045666 positive regulation of neuron differentiation 3.21e-03 4.77e-02 4.32e-01 3.94e-01 1.59e+00
go:2000781 positive regulation of double-strand break repair 3.22e-03 4.77e-02 4.32e-01 6.53e-01 1.77e+00
go:1990204 oxidoreductase complex 3.29e-03 4.84e-02 4.32e-01 -3.64e-01 -1.63e+00
go:0120034 positive regulation of plasma membrane bounded cell projection assembly 3.44e-03 5.05e-02 4.32e-01 5.24e-01 1.72e+00
go:0098794 postsynapse 3.47e-03 5.05e-02 4.32e-01 3.58e-01 1.54e+00
go:0032467 positive regulation of cytokinesis 3.49e-03 5.05e-02 4.32e-01 6.28e-01 1.77e+00
go:0048646 anatomical structure formation involved in morphogenesis 3.50e-03 5.05e-02 4.32e-01 3.14e-01 1.43e+00
go:0030595 leukocyte chemotaxis 3.52e-03 5.06e-02 4.32e-01 -4.29e-01 -1.68e+00
go:0044463 3.57e-03 5.10e-02 4.32e-01 2.92e-01 1.37e+00
go:0002064 epithelial cell development 3.62e-03 5.14e-02 4.32e-01 4.20e-01 1.64e+00
go:1902275 regulation of chromatin organization 3.65e-03 5.16e-02 4.32e-01 3.95e-01 1.59e+00
go:0007492 endoderm development 3.68e-03 5.17e-02 4.32e-01 5.51e-01 1.74e+00
go:0048638 regulation of developmental growth 3.68e-03 5.17e-02 4.32e-01 3.96e-01 1.59e+00
go:1901699 cellular response to nitrogen compound 3.73e-03 5.20e-02 4.32e-01 3.31e-01 1.47e+00
go:0032153 cell division site 3.72e-03 5.20e-02 4.32e-01 5.06e-01 1.73e+00
go:0051783 regulation of nuclear division 3.77e-03 5.22e-02 4.32e-01 3.78e-01 1.55e+00
reactome:R-HSA-5610780 Degradation of GLI1 by the proteasome 3.77e-03 5.22e-02 4.32e-01 -4.14e-01 -1.66e+00
go:0005125 cytokine activity 3.88e-03 5.34e-02 4.32e-01 -5.13e-01 -1.82e+00
go:0051301 cell division 3.89e-03 5.34e-02 4.32e-01 3.07e-01 1.42e+00
go:0048471 perinuclear region of cytoplasm 3.92e-03 5.34e-02 4.07e-01 3.11e-01 1.42e+00
go:0051240 positive regulation of multicellular organismal process 3.92e-03 5.34e-02 4.07e-01 2.86e-01 1.36e+00
go:0006356 regulation of transcription by RNA polymerase I 3.95e-03 5.36e-02 4.07e-01 6.22e-01 1.76e+00
go:0030424 axon 4.03e-03 5.43e-02 4.07e-01 3.50e-01 1.50e+00
go:0002183 cytoplasmic translational initiation 4.04e-03 5.43e-02 4.07e-01 5.49e-01 1.73e+00
reactome:R-HSA-373755 Semaphorin interactions 4.08e-03 5.46e-02 4.07e-01 5.78e-01 1.78e+00
go:0030545 receptor regulator activity 4.10e-03 5.47e-02 4.07e-01 -3.69e-01 -1.60e+00
go:0000790 chromatin 4.14e-03 5.47e-02 4.07e-01 3.51e-01 1.50e+00
go:0097529 myeloid leukocyte migration 4.12e-03 5.47e-02 4.07e-01 -4.39e-01 -1.68e+00
go:0006936 muscle contraction 4.13e-03 5.47e-02 4.07e-01 4.11e-01 1.62e+00
go:0009055 electron transfer activity 4.18e-03 5.50e-02 4.07e-01 -3.69e-01 -1.60e+00
go:1905268 negative regulation of chromatin organization 4.22e-03 5.53e-02 4.07e-01 5.47e-01 1.73e+00
reactome:R-HSA-5689901 Metalloprotease DUBs 4.42e-03 5.77e-02 4.07e-01 -5.81e-01 -1.84e+00
go:0015931 nucleobase-containing compound transport 4.50e-03 5.81e-02 4.07e-01 3.56e-01 1.52e+00
go:0005126 cytokine receptor binding 4.50e-03 5.81e-02 4.07e-01 -3.92e-01 -1.63e+00
reactome:R-HSA-9020702 Interleukin-1 signaling 4.50e-03 5.81e-02 4.07e-01 -3.91e-01 -1.63e+00
go:0007167 enzyme linked receptor protein signaling pathway 4.56e-03 5.84e-02 4.07e-01 2.96e-01 1.37e+00
go:0000228 nuclear chromosome 4.61e-03 5.84e-02 4.07e-01 3.13e-01 1.42e+00
go:0043484 regulation of RNA splicing 4.58e-03 5.84e-02 4.07e-01 4.00e-01 1.60e+00
go:0060341 regulation of cellular localization 4.56e-03 5.84e-02 4.07e-01 2.96e-01 1.38e+00
go:0000781 chromosome, telomeric region 4.61e-03 5.84e-02 4.07e-01 4.03e-01 1.60e+00
reactome:R-HSA-5651801 PCNA-Dependent Long Patch Base Excision Repair 4.71e-03 5.85e-02 4.07e-01 -6.05e-01 -1.86e+00
go:0017171 serine hydrolase activity 4.70e-03 5.85e-02 4.07e-01 -5.15e-01 -1.77e+00
go:1902903 regulation of supramolecular fiber organization 4.71e-03 5.85e-02 4.07e-01 3.54e-01 1.49e+00
go:0050806 positive regulation of synaptic transmission 4.70e-03 5.85e-02 4.07e-01 5.43e-01 1.72e+00
go:0010639 negative regulation of organelle organization 5.01e-03 6.16e-02 4.07e-01 3.43e-01 1.50e+00
go:0003678 DNA helicase activity 5.00e-03 6.16e-02 4.07e-01 5.42e-01 1.71e+00
reactome:R-HSA-73933 Resolution of Abasic Sites (AP sites) 4.99e-03 6.16e-02 4.07e-01 -5.20e-01 -1.77e+00
go:0016758 transferase activity, transferring hexosyl groups 5.05e-03 6.18e-02 4.07e-01 -3.99e-01 -1.65e+00
go:0070987 error-free translesion synthesis 5.13e-03 6.25e-02 4.07e-01 -6.01e-01 -1.85e+00
reactome:R-HSA-110320 Translesion Synthesis by POLH 5.13e-03 6.25e-02 4.07e-01 -6.01e-01 -1.85e+00
msig:M16853 KEGG_DNA_REPLICATION 5.20e-03 6.31e-02 4.07e-01 -5.11e-01 -1.75e+00
go:0050808 synapse organization 5.22e-03 6.31e-02 4.07e-01 3.72e-01 1.52e+00
go:0002520 immune system development 5.30e-03 6.35e-02 4.07e-01 3.01e-01 1.39e+00
go:0009790 embryo development 5.30e-03 6.35e-02 4.07e-01 3.03e-01 1.39e+00
reactome:R-HSA-174417 Telomere C-strand (Lagging Strand) Synthesis 5.35e-03 6.38e-02 4.07e-01 -5.98e-01 -1.84e+00
reactome:R-HSA-381340 Transcriptional regulation of white adipocyte differentiation 5.44e-03 6.46e-02 4.07e-01 -4.50e-01 -1.67e+00
go:0005198 structural molecule activity 5.48e-03 6.47e-02 4.07e-01 3.01e-01 1.39e+00
go:0120111 neuron projection cytoplasm 5.47e-03 6.47e-02 4.07e-01 5.01e-01 1.68e+00
go:0071824 protein-DNA complex subunit organization 5.56e-03 6.55e-02 4.07e-01 3.57e-01 1.50e+00
go:0005839 proteasome core complex 5.64e-03 6.61e-02 4.07e-01 -6.12e-01 -1.82e+00
go:0031056 regulation of histone modification 5.65e-03 6.61e-02 4.07e-01 4.16e-01 1.62e+00
reactome:R-HSA-110373 Resolution of AP sites via the multiple-nucleotide patch replacement pathway 5.67e-03 6.61e-02 4.07e-01 -5.72e-01 -1.84e+00
go:0090199 regulation of release of cytochrome c from mitochondria 5.76e-03 6.67e-02 4.07e-01 -5.40e-01 -1.77e+00
go:0031098 stress-activated protein kinase signaling cascade 5.75e-03 6.67e-02 4.07e-01 3.87e-01 1.56e+00
go:0030031 cell projection assembly 5.80e-03 6.70e-02 4.07e-01 3.21e-01 1.43e+00
reactome:R-HSA-9012999 RHO GTPase cycle 5.89e-03 6.75e-02 4.07e-01 5.02e-01 1.65e+00
go:0006360 transcription by RNA polymerase I 5.89e-03 6.75e-02 4.07e-01 4.92e-01 1.66e+00
go:0032784 regulation of DNA-templated transcription, elongation 6.00e-03 6.86e-02 4.07e-01 5.38e-01 1.72e+00
go:0050877 nervous system process 6.04e-03 6.88e-02 4.07e-01 3.46e-01 1.50e+00
go:0005635 nuclear envelope 6.08e-03 6.91e-02 4.07e-01 3.20e-01 1.42e+00
go:0042734 presynaptic membrane 6.15e-03 6.96e-02 4.07e-01 5.87e-01 1.78e+00
go:0098632 cell-cell adhesion mediator activity 6.28e-03 7.09e-02 4.07e-01 6.09e-01 1.72e+00
go:1990904 ribonucleoprotein complex 6.44e-03 7.16e-02 4.07e-01 2.66e-01 1.29e+00
go:0006354 DNA-templated transcription, elongation 6.40e-03 7.16e-02 4.07e-01 3.99e-01 1.56e+00
go:0007417 central nervous system development 6.44e-03 7.16e-02 4.07e-01 3.10e-01 1.41e+00
go:0014855 striated muscle cell proliferation 6.39e-03 7.16e-02 4.07e-01 6.03e-01 1.73e+00
go:0043087 regulation of GTPase activity 6.37e-03 7.16e-02 4.07e-01 3.57e-01 1.50e+00
go:0051028 mRNA transport 6.51e-03 7.17e-02 4.07e-01 3.66e-01 1.50e+00
reactome:R-HSA-5685942 HDR through Homologous Recombination (HRR) 6.62e-03 7.27e-02 4.07e-01 -4.42e-01 -1.64e+00
go:0003729 mRNA binding 6.77e-03 7.40e-02 4.07e-01 3.50e-01 1.49e+00
go:2001251 negative regulation of chromosome organization 6.79e-03 7.40e-02 4.07e-01 4.07e-01 1.59e+00
go:0070252 actin-mediated cell contraction 6.92e-03 7.52e-02 4.07e-01 5.33e-01 1.70e+00
reactome:R-HSA-5619084 ABC transporter disorders 7.02e-03 7.56e-02 4.07e-01 -4.03e-01 -1.66e+00
go:0032465 regulation of cytokinesis 7.01e-03 7.56e-02 4.07e-01 4.77e-01 1.65e+00
reactome:R-HSA-9604323 Negative regulation of NOTCH4 signaling 7.04e-03 7.56e-02 4.07e-01 -4.00e-01 -1.61e+00
go:0030261 chromosome condensation 7.11e-03 7.57e-02 4.07e-01 5.72e-01 1.74e+00
go:0008022 protein C-terminus binding 7.12e-03 7.57e-02 4.07e-01 3.91e-01 1.56e+00
go:0032102 negative regulation of response to external stimulus 7.08e-03 7.57e-02 4.07e-01 -3.42e-01 -1.51e+00
go:0048285 organelle fission 7.22e-03 7.64e-02 4.07e-01 3.21e-01 1.42e+00
go:0016491 oxidoreductase activity 7.24e-03 7.64e-02 4.07e-01 -2.45e-01 -1.30e+00
go:0043967 histone H4 acetylation 7.29e-03 7.66e-02 4.07e-01 5.08e-01 1.65e+00
go:0044839 cell cycle G2/M phase transition 7.33e-03 7.69e-02 4.07e-01 3.37e-01 1.47e+00
go:0046330 positive regulation of JNK cascade 7.37e-03 7.71e-02 4.07e-01 5.30e-01 1.69e+00
go:0001706 endoderm formation 7.42e-03 7.72e-02 4.07e-01 5.99e-01 1.72e+00
go:0022412 cellular process involved in reproduction in multicellular organism 7.43e-03 7.72e-02 4.07e-01 3.96e-01 1.55e+00
go:0044770 cell cycle phase transition 7.52e-03 7.79e-02 4.07e-01 2.91e-01 1.35e+00
reactome:R-HSA-194315 Signaling by Rho GTPases 7.53e-03 7.79e-02 4.07e-01 3.19e-01 1.41e+00
go:0048010 vascular endothelial growth factor receptor signaling pathway 7.64e-03 7.87e-02 4.07e-01 4.95e-01 1.65e+00
go:0031490 chromatin DNA binding 7.69e-03 7.88e-02 4.07e-01 4.52e-01 1.62e+00
reactome:R-HSA-5653656 Vesicle-mediated transport 7.69e-03 7.88e-02 4.07e-01 2.96e-01 1.37e+00
go:0031330 negative regulation of cellular catabolic process 7.78e-03 7.93e-02 4.07e-01 3.67e-01 1.51e+00
reactome:R-HSA-9013694 Signaling by NOTCH4 7.79e-03 7.93e-02 4.07e-01 -3.77e-01 -1.59e+00
reactome:R-HSA-4608870 Asymmetric localization of PCP proteins 7.82e-03 7.95e-02 3.81e-01 -4.02e-01 -1.58e+00
go:0060589 nucleoside-triphosphatase regulator activity 7.91e-03 7.99e-02 3.81e-01 3.63e-01 1.49e+00
go:0032201 telomere maintenance via semi-conservative replication 7.96e-03 7.99e-02 3.81e-01 -5.65e-01 -1.77e+00
go:0007018 microtubule-based movement 7.95e-03 7.99e-02 3.81e-01 3.65e-01 1.49e+00
go:0048738 cardiac muscle tissue development 8.02e-03 8.01e-02 3.81e-01 4.43e-01 1.63e+00
go:0016298 lipase activity 8.01e-03 8.01e-02 3.81e-01 -5.97e-01 -1.77e+00
go:0044068 modulation by symbiont of host cellular process 8.12e-03 8.02e-02 3.81e-01 6.12e-01 1.66e+00
go:0042180 cellular ketone metabolic process 8.08e-03 8.02e-02 3.81e-01 -3.38e-01 -1.51e+00
go:0032870 cellular response to hormone stimulus 8.11e-03 8.02e-02 3.81e-01 3.14e-01 1.41e+00
go:0051345 positive regulation of hydrolase activity 8.10e-03 8.02e-02 3.81e-01 3.07e-01 1.38e+00
reactome:R-HSA-5678895 Defective CFTR causes cystic fibrosis 8.19e-03 8.06e-02 3.81e-01 -3.82e-01 -1.55e+00
go:0045309 protein phosphorylated amino acid binding 8.21e-03 8.07e-02 3.81e-01 5.99e-01 1.69e+00
go:0007052 mitotic spindle organization 8.30e-03 8.13e-02 3.81e-01 4.21e-01 1.60e+00
go:0030427 site of polarized growth 8.35e-03 8.16e-02 3.81e-01 4.34e-01 1.59e+00
go:0006323 DNA packaging 8.43e-03 8.22e-02 3.81e-01 3.89e-01 1.55e+00
go:0098978 glutamatergic synapse 8.48e-03 8.24e-02 3.81e-01 3.78e-01 1.52e+00
go:0035591 signaling adaptor activity 8.58e-03 8.31e-02 3.81e-01 5.73e-01 1.73e+00
go:0051248 negative regulation of protein metabolic process 8.60e-03 8.31e-02 3.81e-01 2.83e-01 1.33e+00
go:0032392 DNA geometric change 8.63e-03 8.32e-02 3.81e-01 4.25e-01 1.59e+00
go:0010720 positive regulation of cell development 8.71e-03 8.32e-02 3.81e-01 3.39e-01 1.46e+00
go:0043297 apical junction assembly 8.79e-03 8.32e-02 3.81e-01 5.62e-01 1.75e+00
reactome:R-HSA-4641258 Degradation of DVL 8.79e-03 8.32e-02 3.81e-01 -3.98e-01 -1.57e+00
reactome:R-HSA-69541 Stabilization of p53 8.75e-03 8.32e-02 3.81e-01 -3.92e-01 -1.57e+00
go:0003774 motor activity 8.75e-03 8.32e-02 3.81e-01 4.59e-01 1.62e+00
go:0005871 kinesin complex 8.77e-03 8.32e-02 3.81e-01 5.92e-01 1.73e+00
go:0070849 response to epidermal growth factor 8.67e-03 8.32e-02 3.81e-01 5.63e-01 1.75e+00
go:0045935 positive regulation of nucleobase-containing compound metabolic process 8.86e-03 8.34e-02 3.81e-01 3.56e-01 1.49e+00
reactome:R-HSA-73929 Base-Excision Repair, AP Site Formation 8.86e-03 8.34e-02 3.81e-01 -5.93e-01 -1.76e+00
go:0007264 small GTPase mediated signal transduction 9.01e-03 8.45e-02 3.81e-01 3.24e-01 1.42e+00
reactome:R-HSA-69186 Lagging Strand Synthesis 9.05e-03 8.47e-02 3.81e-01 -5.92e-01 -1.76e+00
go:0016655 oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor 9.09e-03 8.49e-02 3.81e-01 -3.95e-01 -1.62e+00
go:0040014 regulation of multicellular organism growth 9.13e-03 8.50e-02 3.81e-01 5.85e-01 1.75e+00
go:0034330 cell junction organization 9.22e-03 8.56e-02 3.81e-01 3.60e-01 1.49e+00
go:0001508 action potential 9.31e-03 8.61e-02 3.81e-01 5.45e-01 1.72e+00
go:0019953 sexual reproduction 9.32e-03 8.61e-02 3.81e-01 3.22e-01 1.43e+00
reactome:R-HSA-446652 Interleukin-1 family signaling 9.37e-03 8.63e-02 3.81e-01 -3.62e-01 -1.55e+00
go:1904888 cranial skeletal system development 9.41e-03 8.65e-02 3.81e-01 5.90e-01 1.73e+00
go:0032504 multicellular organism reproduction 9.49e-03 8.70e-02 3.81e-01 3.24e-01 1.44e+00
go:0060996 dendritic spine development 9.55e-03 8.71e-02 3.81e-01 4.84e-01 1.59e+00
go:0071242 cellular response to ammonium ion 9.55e-03 8.71e-02 3.81e-01 5.94e-01 1.68e+00
reactome:R-HSA-5632684 Hedgehog 'on' state 9.70e-03 8.83e-02 3.81e-01 -3.93e-01 -1.62e+00
go:0032154 cleavage furrow 9.74e-03 8.83e-02 3.81e-01 5.04e-01 1.66e+00
go:0045596 negative regulation of cell differentiation 9.75e-03 8.83e-02 3.81e-01 3.20e-01 1.41e+00
go:0060326 cell chemotaxis 9.88e-03 8.92e-02 3.81e-01 -3.70e-01 -1.57e+00
go:0098609 cell-cell adhesion 9.99e-03 8.99e-02 3.81e-01 3.22e-01 1.42e+00
go:0051168 nuclear export 1.01e-02 9.05e-02 3.81e-01 3.37e-01 1.43e+00
go:0000070 mitotic sister chromatid segregation 1.01e-02 9.05e-02 3.81e-01 3.66e-01 1.49e+00
go:0045740 positive regulation of DNA replication 1.04e-02 9.11e-02 3.81e-01 5.91e-01 1.67e+00
go:0007276 gamete generation 1.04e-02 9.11e-02 3.81e-01 3.27e-01 1.42e+00
go:0036475 neuron death in response to oxidative stress 1.04e-02 9.11e-02 3.81e-01 6.06e-01 1.64e+00
go:0009792 embryo development ending in birth or egg hatching 1.04e-02 9.11e-02 3.81e-01 3.16e-01 1.40e+00
reactome:R-HSA-8852276 The role of GTSE1 in G2/M progression after G2 checkpoint 1.03e-02 9.11e-02 3.81e-01 -3.70e-01 -1.57e+00
go:0060090 molecular adaptor activity 1.03e-02 9.11e-02 3.81e-01 3.96e-01 1.53e+00
go:0005874 microtubule 1.05e-02 9.17e-02 3.81e-01 3.30e-01 1.44e+00
go:0051653 spindle localization 1.05e-02 9.18e-02 3.81e-01 5.47e-01 1.66e+00
go:0000819 sister chromatid segregation 1.06e-02 9.23e-02 3.81e-01 3.64e-01 1.52e+00
go:1902369 negative regulation of RNA catabolic process 1.07e-02 9.24e-02 3.81e-01 5.36e-01 1.69e+00
go:0002682 regulation of immune system process 1.08e-02 9.28e-02 3.81e-01 2.79e-01 1.32e+00
go:0007281 germ cell development 1.07e-02 9.28e-02 3.81e-01 4.20e-01 1.56e+00
reactome:R-HSA-6802952 Signaling by BRAF and RAF1 fusions 1.08e-02 9.28e-02 3.81e-01 5.18e-01 1.66e+00
go:0010257 NADH dehydrogenase complex assembly 1.08e-02 9.28e-02 3.81e-01 -3.85e-01 -1.60e+00
go:0060322 head development 1.10e-02 9.44e-02 3.81e-01 3.06e-01 1.37e+00
go:0008023 transcription elongation factor complex 1.11e-02 9.53e-02 3.81e-01 4.77e-01 1.57e+00
msig:M5898 HALLMARK_DNA_REPAIR 1.13e-02 9.62e-02 3.81e-01 -3.17e-01 -1.46e+00
go:0051015 actin filament binding 1.14e-02 9.69e-02 3.81e-01 4.11e-01 1.57e+00
go:0016358 dendrite development 1.14e-02 9.71e-02 3.81e-01 4.18e-01 1.58e+00
go:0090169 regulation of spindle assembly 1.16e-02 9.82e-02 3.81e-01 5.83e-01 1.70e+00
go:0000003 reproduction 1.18e-02 9.97e-02 3.81e-01 2.80e-01 1.31e+00
go:0043405 regulation of MAP kinase activity 1.19e-02 9.97e-02 3.81e-01 3.58e-01 1.47e+00

Literature Mining

INDRA was used to automatically assemble known mechanisms related to UCHL3 from literature and knowledge bases. The first section shows only DUB activity and the second shows all other results.

Deubiquitinase Activity

psp cbn pc bel_lc signor biogrid tas hprd trrust ctd vhn pe drugbank omnipath conib crog dgi minerva creeds ubibrowser acsn | geneways tees gnbr semrep isi trips rlimsp medscan eidos sparser reach
UCHL3 deubiquitinates RAD51. 6 / 6
1 | 5
reach
UCHL3 deubiquitinates RAD51 thereby promoting the recruitment of RAD51 to DNA damage sites and augmenting DNA repair.
31113933
reach
RAD51 deubiquitination by UCHL3 was observed both in vitro and in cellulo and shown to be critical for BRCA2-RAD51 interaction, RAD51 recruitment to DSB sites, foci formation, as well as RAD51 mediated D-loop formation [XREF_BIBR].
| PMC
reach
After DNA damages, UCHL3 is activated via phosphorylation by ATM and then deubiquitinates RAD51 promoting RAD51-BRCA2 interaction and proper HR repair [150].
28552167
reach
found that UCHL3 deubiquitinates RAD51 and subsequently facilitates RAD51-BRCA2 interaction, which is critical for homologous recombination (HR) and contributes to therapeutic resistance in breast cancer.
33585209
reach
UCHL3, in turn, deubiquitinates RAD51 and promotes the binding between RAD51 and BRCA2.
27941124
ubibrowser
UCHL3, in turn, deubiquitinates RAD51 and promotes the binding between RAD51 and BRCA2.
27941124
UCHL3 deubiquitinates COPS5. 4 / 4
| 4
reach
Given that UCHL3 interacts with COPS5 in IFN signaling and UCHL3 is a deubiquitinase, we question whether UCHL3 promotes COPS5 deubiquitination.
28583475
reach
To address this question, we firstly performed an in vitro deubiquitination assay, which clearly demonstrated that UCHL3 can deubiquitinate COPS5 in vitro.
28583475
reach
These results imply that UCHL3 physically interacts with COPS5 and deubiquitinates COPS5.Given that UCHL3 can deubiquitinate COPS5, we speculate that UCHL3 could affect cellular levels of COPS5.
28583475
reach
Furthermore, we demonstrate that UCHL3 as a deubiquitinase can deubiquitinate COPS5, thereby upregulating COPS5 levels and protein stability (Figs. 4 and 5).
28583475
UCHL3 deubiquitinates FOXM1. 2 / 2
| 2
reach
Furthermore, knockdown of UCHL3 increased FOXM1 ubiquitination, which enhanced FOXM1 turnover and promoted pancreatic cancer cells ' sensitivity to gemcitabine.
31598398
reach
Deubiquitination of FOXM1 by UCHL3 was also shown to promote pancreatic cancer progression and gemcitabine resistance.
33680951
UCHL3 leads to the deubiquitination of TRAF2. 2 / 2
| 2
reach
UCHL3 was found to activate NF-kappaB signalling by deubiquitinating and stabilizing TRAF2, leading to tumourigenesis.
31477831
reach
The elevated UCHL3 facilitates carcinogenesis and enhances inflammation by deubiquitinating and stabilizing TNF Receptor Associated Factor 2 (TRAF2).
33585209
UCHL3 leads to the deubiquitination of TDP1. 1 / 1
| 1
reach
In contrast, UCHL3 is downregulated in spinocerebellar ataxia with axonal neuropathy (SCAN1), causing elevated levels of TDP1 ubiquitylation and faster turnover rate.
29898404
UCHL3 deubiquitinates RAD51B. 1 / 1
1 |
ubibrowser
Mechanistically, in response to DNA damage, the deubiquitinase UCHL3 is phosphorylated and activated by ATM. UCHL3, in turn, deubiquitinates RAD51 and promotes the binding between RAD51 and BRCA2.
27941124
UCHL3 deubiquitinates PPARG. 1 / 1
| 1
reach
In addition, recombinant UCHL3 failed to deubiquitinate PPARgamma in vitro (XREF_SUPPLEMENTARY and XREF_SUPPLEMENTARY), indicating that UCHL3 modulates PPARgamma activity by an indirect mechanism, either through its ubiquitin hydrolase or its deneddylase activity.
22679485
UCHL3 deubiquitinates MCL1. 1 / 1
| 1
reach
Cdu1, but not the control enzyme UCH-L3 strongly deubiquitinated Mcl-1 (XREF_FIG).
28347402
UCHL3 deubiquitinates STUB1. 1 / 1
| 1
reach
No other tested DUB behaved in a similar manner : USP5 deubiquitinated Ub-CHIP in an unregulated manner, while UCHL-1 and UCHL-3 did not deubiquitinate Ub-CHIP under any conditions (XREF_FIG).
21855799
UCHL3 deubiquitinates SMAD1. 1 / 1
1 |
ubibrowser
Ubiquitin C-terminal hydrolase-L3 regulates Smad1 ubiquitination and osteoblast differentiation.
21453705
Modified UCHL3 leads to the deubiquitination of TDP1. 1 / 1
| 1
reach
Overexpression of UCHL3, but not a catalytically inactive mutant, suppresses TDP1 ubiquitylation and turnover rate.
29898404

Other Statements

psp cbn pc bel_lc signor biogrid tas hprd trrust ctd vhn pe drugbank omnipath conib crog dgi minerva creeds ubibrowser acsn | geneways tees gnbr semrep isi trips rlimsp medscan eidos sparser reach
reach
The induction of EMT by UCH-L3 knockdown results in an increase of cell migration and invasion.
25194810
reach
UCH-L3 was found to be downregulated in the highly metastatic prostate cell lines, and knockdown of UCH-L3 induced EMT process.
28279784
reach
Contrarily, overexpression of UCH-L3 in the highly metastatic prostate cell line PC3 reverses EMT depending on the deubiquitinating activity of UCH-L3.
25194810
reach
The reverse of the EMT event caused by UCH-L3 overexpression in PC3 coincided with a decrease of cell migration and invasion.UCH-L3 and UCH-L1 are very close relatives with high amino acid identity an[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
25194810
reach
Yet, to the contrary, overexpression of UCH-L3 in highly metastatic prostate cancer cell line PC3 reverses EMT but the active site mutant UCH-L3 did not.
25194810
reach
As shown in Fig. 2 B, knockdown of UCH-L3 induces the molecular alterations of EMT.
25194810
eidos
By contrast , UCHL3 is reduced in metastatic prostate cancer cell lines , and knockdown of UCHL3 promotes epithelial-to-mesenchymal transition ( EMT ) , contributing to cancer cell invasion and metastasis ( 102 ) .
33585209
sparser
These results indicate that UCH-L3 inhibits EMT by repression of EMT promoting genes such as Snail , Slug , Twist , and MMPs in normal prostate cell lines.
25194810
reach
These results indicate that UCH-L3 inhibits EMT by repression of EMT promoting genes such as Snail, Slug, Twist, and MMPs in normal prostate cell lines.In our previous report, we found that UCH-L1 exp[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
25194810
reach
We found that knockdown of UCH-L3 induced EMT process.
25194810
reach
Knockdown of UCH-L3 in the normal prostate cell line RWPE1 induces morphological and molecular events of EMT.
25194810
reach
We have already shown that UCH-L1, a close relative of UCH-L3, induces EMT and promotes metastasis in prostate cancer cells [11].
25194810
UCHL3 increases the amount of epithelial to mesenchymal transition.
| 1
Modified UCHL3 increases the amount of epithelial to mesenchymal transition. 1 / 1
| 1
reach
The alterations of the EMT marker expression induced by UCH-L3 overexpression in PC3 stable cells coincided with the change of migratory and invasive properties.
25194810
Ubiquitin affects UCHL3
| 1 4 6
Ubiquitin inhibits UCHL3.
| 1 4 5
Ubiquitin inhibits UCHL3. 10 / 11
| 1 4 5
reach
As an additional control experiment, we measured a K i of 0.27 mM for the inhibition of UCH-L3 by ubiquitin with the substrate ubiquitin-AMC.
16905103
reach
As an additional control experiment, we measured a K i of 0.27 muM for the inhibition of UCH-L3 by ubiquitin with the substrate ubiquitin-AMC.
16905103
sparser
Using our Ub tools to profile UCHL3's activity, we generate a quantitative kinetic model of the inhibitory mechanism and we find that K27 Ub 2 can inhibit UCHL3 covalently, by binding to its catalytic cysteine, and allosterically, by locking its catalytic loop tightly in place.
33238157
sparser
As an additional control experiment, we measured a K i of 0.27 mM for the inhibition of UCH-L3 by ubiquitin with the substrate ubiquitin-AMC.
16905103
reach
As an additional control experiment, we measured a Ki of 0.27 μM for the inhibition of UCH-L3 by ubiquitin with the substrate ubiquitin-AMC.
16905103
sparser
As an additional control experiment, we measured a K of 0.27 μM for the inhibition of UCH-L3 by ubiquitin with the substrate ubiquitin-AMC.
16905103
sparser
As an additional control experiment, we measured a Ki of 0.27 μM for the inhibition of UCH-L3 by ubiquitin with the substrate ubiquitin-AMC.
16905103
reach
The present data demonstrated that ubiquitin aldehyde can inhibit the activity of UCHL3.
27780264
reach
(2) The kinetics of inhibition of UCH-L3 by ubiquitin C-terminal aldehyde (Ub-H) were determined and reveal a Ki that is less than 10 (-14) M. Several mechanisms are considered to account for the extreme inhibition.
9485312
eidos
As an additional control experiment , we measured a K i of 0.27 mM for the inhibition of UCH-L3 by ubiquitin with the substrate ubiquitin-AMC .
16905103
Ubiquitin increases the amount of UCHL3.
| 1
Ubiquitin increases the amount of UCHL3. 1 / 1
| 1
reach
Therefore, ubiquitin aldehyde may modulate the protein expression and function of UCHL3.
27780264
Valproic acid affects UCHL3
8 |
Valproic acid increases the amount of UCHL3. 8 / 8
8 |
ctd
No evidence text available
25192806
ctd
No evidence text available
24383497
ctd
No evidence text available
27188386
ctd
No evidence text available
29154799
ctd
No evidence text available
28001369
ctd
No evidence text available
24935251
ctd
No evidence text available
26272509
ctd
No evidence text available
23179753
UCHL3 affects COPS5
| 8
UCHL3 increases the amount of COPS5.
| 5
UCHL3 bound to COPS5 increases the amount of COPS5. 2 / 2
| 2
reach
We demonstrate that UCHL3 physically interacts with COPS5, and increases COPS5 levels and protein stability by deubiquitinating COPS5.
28583475
reach
Next, we find that UCHL3 physically interacts with COPS5, and upregulates COPS5 levels and protein stability by deubiquitinating COPS5.
28583475
UCHL3 increases the amount of COPS5. 2 / 2
| 2
reach
Furthermore, we demonstrate that UCHL3 as a deubiquitinase can deubiquitinate COPS5, thereby upregulating COPS5 levels and protein stability (Figs. 4 and 5).
28583475
reach
In summary, our results demonstrate that UCHL3 upregulates the levels of SCF beta-TrCP substrates.We have demonstrated that UCHL3 positively regulated COPS5 levels and IFNAR1 levels.
28583475
Modified UCHL3 increases the amount of COPS5. 1 / 1
| 1
reach
Meanwhile, endogenous COPS5 levels were also gradually upregulated by overexpression of increased amounts of UCHL3.
28583475
UCHL3 decreases the amount of COPS5.
| 2
UCHL3 decreases the amount of COPS5. 2 / 2
| 2
reach
Since COPS5 have been demonstrated to downregulate Cullin1 neddylation and activity, we speculate that UCHL3 could downregulate the activity of SCF beta and TrCP complex by upregulating cellular COPS5[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
28583475
reach
We found that UCHL3 knockdown noticeably upregulated ubiquitination levels of COPS5.
28583475
UCHL3 activates COPS5.
| 1
UCHL3 activates COPS5. 1 / 1
| 1
reach
The result showed that FH-UCHL3 overexpression obviously blocked protein degradation of COPS5, suggesting that UCHL3 enhances COPS5 protein stability.
28583475
UCHL3 affects CUL1
| 7
UCHL3 inhibits CUL1.
| 4
UCHL3 inhibits CUL1. 4 / 4
| 4
reach
We reveal that UCHL3 can inhibit Cullin1 neddylation in cells dependently on COPS5.
28583475
reach
We found that overexpression of increased amounts of UCHL3 gradually inhibited endogenous Cullin1 neddylation, indicating that cellular Cullin1 neddylation are regulated by UCHL3 levels.
28583475
reach
Our results showed that UCHL3 overexpression inhibits Cullin1 neddylation.
28583475
reach
We find that in cells UCHL3 can decrease neddylation of Cullin1.
28583475
UCHL3 activates CUL1.
| 2
UCHL3 activates CUL1. 2 / 2
| 2
reach
Subsequently, UCHL3 mediated upregulation of COPS5 promotes Cullin1 deneddylation.
28583475
reach
However, we found that knockout of COPS5 abolished the effect of UCHL3 on Cullin1 deneddylation, indicating that COPS5 is required for UCHL3 mediated deneddylation of Cullin1 in cells.
28583475
UCHL3 decreases the amount of CUL1.
| 1
Modified UCHL3 decreases the amount of CUL1. 1 / 1
| 1
reach
Our data showed that overexpression of UCHL3 in COPS5-wild type (WT) cells robustly decreased Cullin1 neddylation levels, consistent with our previous observation.
28583475
UCHL3 activates cell population proliferation. 5 / 5
| 5
reach
UCH-L3 knockdown significantly inhibited the proliferation of NSCLC cells, whereas UCH-L3 overexpression had the opposite effect.
32180254
reach
UCHL3 promotes proliferation of colorectal cancer cells by regulating SOX12 via AKT and mTOR signaling pathway.
33194042
reach
UCH-L3 promotes non small cell lung cancer proliferation via accelerating cell cycle and inhibiting cell apoptosis.
32180254
reach
Moreover, UCH-L3 promoted NSCLC cells proliferation via accelerating cell cycle and inhibiting cell apoptosis.
32180254
reach
Taken together, the results of the present study suggest that UCHL3 knockdown decreases melanoma cell proliferation by increasing cell autophagy through regulating NEDD8 expression and autophagosome numbers.
34539860
UCHL3 inhibits cell population proliferation. 1 / 1
| 1
reach
Genetic ablation of UCHL3 was found to markedly block ovarian cancer cell proliferation, viability and migration both in vitro and in vivo.
31477831
reach
Even though the function of UCH-L3 in neurons has not been elucidated to the extent of our knowledge, it may be plausible that there can be reciprocal or differential functions of UCH-L3 to the UCH-L1[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
25194810
reach
These results suggest that Uch-L3 enhances osteoblast differentiation through the stabilization of Smad1 signaling.
21453705
reach
Consequently, it was suggested that UCHL3 stabilizes Smad1 signaling, which may explain the enhanced osteoblast differentiation caused by UCHL3 overexpression.
29898404
Modified UCHL3 activates cell differentiation. 1 / 1
| 1
reach
Moreover, ectopic expression of wild-type UCH-L3 restored the phosphorylation of insulin and IGF-I receptor and adipocyte differentiation in Uchl3 (-/-) MEFs.
19837878
UCHL3 affects TDP1
| 5
UCHL3 decreases the amount of TDP1.
| 3
UCHL3 decreases the amount of TDP1. 3 / 3
| 3
reach
Depletion of UCHL3 was sufficient to reduce TDP1 expression in rhabdomyosarcoma cells to levels comparable to control cells (XREF_FIG D, top) and led to hypersensitivity to the TOP1 poison CPT (XREF_FIG D, bottom).
29898404
reach
UCHL3 decreases the ubiquitination level of TDP1 leading to the inhibition of TDP1 degradation.
31967940
reach
Depletion of UCHL3 in rhabdomyosarcoma cells reduced TDP1 levels and sensitized cells to TOP1 poisons.
29898404
UCHL3 increases the amount of TDP1.
| 1
Modified UCHL3 increases the amount of TDP1. 1 / 1
| 1
reach
TDP1 overexpression in the topoisomerase therapy resistant rhabdomyosarcoma is driven by UCHL3 overexpression.
29898404
UCHL3 activates TDP1.
| 1
UCHL3 activates TDP1. 1 / 1
| 1
reach
Depletion of UCHL3 in rhabdomyosarcoma cells markedly accelerated TDP1 turnover, as measured by CHX chase experiments (XREF_FIG B).
29898404
UCHL3 affects KITLG
| 4
UCHL3 activates KITLG. 4 / 4
| 4
reach
We further demonstrate that UCHL3 upregulates the levels of SCF beta-TrCP substrates including IFN-I receptor IFNAR1, which enhances IFN-I mediated signaling pathway and antiviral activity.
28583475
reach
Furthermore, we reveal that UCHL3 increases levels of SCF beta-TrCP substrates and enhances IFN-I mediated signaling and antiviral activity.
28583475
reach
Thus, our findings identify a novel in vivo substrate of UCHL3, and reveal a novel deneddylation regulation by UCHL3.It is interesting that UCHL3 controls the activity of cellular SCF beta and TrCP co[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
28583475
reach
Moreover, we find that UCHL3 upregulates levels of SCF beta-TrCP substrates including IFN-I receptor IFNAR1, thereby enhancing IFN-I mediated signaling and antiviral activity.
28583475
UCHL3 affects UCHL1
| 4
UCHL3 inhibits UCHL1.
| 2
UCHL3 inhibits UCHL1. 2 / 2
| 2
reach
The screening of over 40 000 compounds against the closely related ubiquitin Cterminal hydrolase L1 (UCH-L1) and L3 (UCH-L3) enzymes allowed the development of a UCHL1-specific inhibitor based on an isatin O-acyl oxime scaffold [105] .
28052575
reach
We found that UCH-L1 is highly induced by UCH-L3 knockdown in RWPE1.
25194810
UCHL3 decreases the amount of UCHL1.
| 1
UCHL3 decreases the amount of UCHL1. 1 / 1
| 1
reach
Interestingly, we found that knockdown of UCH-L3 induces the expression of UCH-L1 which is repressed by epigenetic modification in RWPE1.
25194810
UCHL3 activates UCHL1.
| 1
UCHL3 activates UCHL1. 1 / 1
| 1
reach
UCHL1 and UCHL3 are 73% similar but display different patterns of tissue specific gene expression : an upstream neuron-restrictive silencing element (NRSE) drives neuron specific expression in the former and renders it a critical player in neuronal homeostasis (UCHL1 deficiency in neurodegeneration is not physiologically rescued by UCHL3).
28177072
UCHL3 affects IFNAR1
| 4
UCHL3 increases the amount of IFNAR1.
| 3
UCHL3 increases the amount of IFNAR1. 2 / 2
| 2
reach
These findings suggest that UCHL3 could positively regulate IFNAR1 levels via COPS5 mediated deneddylation of Cullin1, which is consistent with our previous findings that UCHL3 positively regulates IF[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
28583475
reach
In summary, our results demonstrate that UCHL3 upregulates the levels of SCF beta-TrCP substrates.We have demonstrated that UCHL3 positively regulated COPS5 levels and IFNAR1 levels.
28583475
Modified UCHL3 increases the amount of IFNAR1. 1 / 1
| 1
reach
The result showed that UCHL3 overexpression gradually increased IFNAR1 levels.
28583475
UCHL3 activates IFNAR1.
| 1
UCHL3 activates IFNAR1. 1 / 1
| 1
reach
This finding suggests that UCHL3 could target either TYK2 itself or IFN-I receptors (IFNAR1 and IFNAR2), which are the direct proteins upstream of TYK2 as well as the first signaling proteins in IFN-I[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
28583475
Trichostatin A affects UCHL3
3 |
Trichostatin A increases the amount of UCHL3. 3 / 3
3 |
ctd
No evidence text available
26272509
ctd
No evidence text available
27188386
ctd
No evidence text available
24935251
Cobalt dichloride affects UCHL3
3 |
Cobalt dichloride decreases the amount of UCHL3. 3 / 3
3 |
ctd
No evidence text available
16622835
ctd
No evidence text available
19376846
ctd
No evidence text available
19320972
UBD affects UCHL3
| 1 1 1
UBD inhibits UCHL3. 3 / 3
| 1 1 1
trips
K27-Linked Diubiquitin Inhibits UCHL3 via an Unusual Kinetic Trap.
33238157
reach
K27 Linked Diubiquitin Inhibits UCHL3 via an Unusual Kinetic Trap.
33238157
sparser
K27-Linked Diubiquitin Inhibits UCHL3 via an Unusual Kinetic Trap.
33238157
JUN affects UCHL3
3 |
JUN decreases the amount of UCHL3. 3 / 3
3 |
biopax:msigdb
No evidence text available
biopax:msigdb
No evidence text available
biopax:msigdb
No evidence text available
UCHL3 affects CTNNB1
| 3
UCHL3 increases the amount of CTNNB1.
| 2
UCHL3 increases the amount of CTNNB1. 1 / 1
| 1
reach
Similarly, knockdown of UCHL3 decreased the expression level of Myc-beta-catenin, and overexpression of UCHL3 upregulated Myc-beta-catenin levels in a dose dependent manner.
28583475
Modified UCHL3 increases the amount of CTNNB1. 1 / 1
| 1
reach
Similarly, knockdown of UCHL3 decreased the expression level of Myc-beta-catenin, and overexpression of UCHL3 upregulated Myc-beta-catenin levels in a dose dependent manner.
28583475
UCHL3 decreases the amount of CTNNB1.
| 1
Modified UCHL3 decreases the amount of CTNNB1. 1 / 1
| 1
reach
Similarly, knockdown of UCHL3 decreased the expression level of Myc-beta-catenin, and overexpression of UCHL3 upregulated Myc-beta-catenin levels in a dose dependent manner.
28583475
Sodium citrate affects UCHL3
| 2
Sodium citrate activates UCHL3. 2 / 2
| 2
reach
Sodium citrate, at high concentrations, activated OTU-1, UCH-L3 and PLpro, and this could be due to an ionic effect or a Hofmeister effect.
18601651
reach
Sodium citrate at 0.8M enhanced activity of UCH-L3 by 12-fold versus 0.8M NaCl for Ac-LRGG-AFC and 20-fold for Ac-ALRGG-AFC (Fig. 5B ).
18601651
reach
Sodium citrate, at high concentrations, activated OTU-1, UCH-L3 and PLpro, and this could be due to an ionic effect or a Hofmeister effect.
18601651
reach
Sodium citrate at 0.8 M enhanced activity of UCH-L3 by 12-fold versus 0.8 M NaCl for Ac-LRGG-AFC and 20-fold for Ac-ALRGG-AFC (XREF_FIG).
18601651
Pirinixic acid affects UCHL3
2 |
Pirinixic acid increases the amount of UCHL3. 2 / 2
2 |
ctd
No evidence text available
23811191
ctd
No evidence text available
18301758
Phenylmercury acetate increases the amount of UCHL3. 2 / 2
2 |
ctd
No evidence text available
26272509
ctd
No evidence text available
27188386
Hsa-miR-875-5p affects UCHL3
2 |
Hsa-miR-875-5p decreases the amount of UCHL3. 2 / 2
2 |
biopax:mirtarbase
No evidence text available
21572407
biopax:mirtarbase
No evidence text available
23446348
Hsa-miR-8485 affects UCHL3
2 |
Hsa-miR-8485 decreases the amount of UCHL3. 2 / 2
2 |
biopax:mirtarbase
No evidence text available
21572407
biopax:mirtarbase
No evidence text available
23446348
Hsa-miR-603 affects UCHL3
2 |
Hsa-miR-603 decreases the amount of UCHL3. 2 / 2
2 |
biopax:mirtarbase
No evidence text available
23446348
biopax:mirtarbase
No evidence text available
21572407
Hsa-miR-5580-3p affects UCHL3
2 |
Hsa-miR-5580-3p decreases the amount of UCHL3. 2 / 2
2 |
biopax:mirtarbase
No evidence text available
23446348
biopax:mirtarbase
No evidence text available
21572407
Hsa-miR-5011-5p affects UCHL3
2 |
Hsa-miR-5011-5p decreases the amount of UCHL3. 2 / 2
2 |
biopax:mirtarbase
No evidence text available
23446348
biopax:mirtarbase
No evidence text available
21572407
Hsa-miR-4789-3p affects UCHL3
2 |
Hsa-miR-4789-3p decreases the amount of UCHL3. 2 / 2
2 |
biopax:mirtarbase
No evidence text available
21572407
biopax:mirtarbase
No evidence text available
23446348
Hsa-miR-3941 affects UCHL3
2 |
Hsa-miR-3941 decreases the amount of UCHL3. 2 / 2
2 |
biopax:mirtarbase
No evidence text available
23446348
biopax:mirtarbase
No evidence text available
21572407
Hsa-miR-362-3p affects UCHL3
2 |
Hsa-miR-362-3p decreases the amount of UCHL3. 2 / 2
2 |
biopax:mirtarbase
No evidence text available
21572407
biopax:mirtarbase
No evidence text available
23446348
Hsa-miR-329-3p affects UCHL3
2 |
Hsa-miR-329-3p decreases the amount of UCHL3. 2 / 2
2 |
biopax:mirtarbase
No evidence text available
23446348
biopax:mirtarbase
No evidence text available
21572407
Hsa-miR-3144-3p affects UCHL3
2 |
Hsa-miR-3144-3p decreases the amount of UCHL3. 2 / 2
2 |
biopax:mirtarbase
No evidence text available
21572407
biopax:mirtarbase
No evidence text available
23446348
Hsa-miR-190a-3p affects UCHL3
2 |
Hsa-miR-190a-3p decreases the amount of UCHL3. 2 / 2
2 |
biopax:mirtarbase
No evidence text available
21572407
biopax:mirtarbase
No evidence text available
23446348
Cyclosporin A affects UCHL3
2 |
Cyclosporin A increases the amount of UCHL3. 2 / 2
2 |
ctd
No evidence text available
20106945
ctd
No evidence text available
25562108
eidos
The elevated UCHL3 facilitates carcinogenesis and enhances inflammation by deubiquitinating and stabilizing TNF Receptor Associated Factor 2 ( TRAF2 ) ( 74 ) .
33585209
reach
Our results indicate that highly expressed UCHL3 enhances inflammation by stabilizing TRAF2, which in turn facilitates tumourigenesis in ovarian cancer, and that UCHL3 is a potential target for ovarian cancer patients with increased inflammation.
31477831
UCHL3 affects TGFB
| 2
UCHL3 activates TGFB. 2 / 2
| 2
reach
Overexpression of UCH-L1, but not of UCH-L3 (the other human homolog of UBH1) or of the catalytic mutant UCH L1C90A, enhanced TGF-beta and SMAD-induced transcriptional activity, indicating that the deubiquitination activity of UCH-L1 is indispensable for enhancing TGF-beta and SMAD signaling.
32371398
reach
Overexpression of UCH-L1, but not of UCH-L3 (the other human homolog of UBH1) or of the catalytic mutant UCH-L1 C90A, enhanced TGF-beta and SMAD-induced transcriptional activity, indicating that the deubiquitination activity of UCH-L1 is indispensable for enhancing TGF-beta and SMAD signaling.
33516505
reach
The invasion through the matrigel was increased by UCH-L3 knockdown.
25194810
reach
In highly metastatic prostate PC3 cells, UCH-L3 inhibits the cell migration and invasion but UCH-L3 C95S had no effects, suggesting that the hydrolase activity of UCH-L3 is required to inhibit the met[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
25194810
UCHL3 affects INS
| 2
UCHL3 activates INS. 2 / 2
| 2
reach
Suzuki et al. have shown that UCHL3 enhances insulin signalling in (pre) adipocytes, but UCHL3 is unlikely to target critical components of insulin signalling like the insulin receptor, the IGF-I receptor, IRS-1 and Grb10 XREF_BIBR.
22679485
reach
These results suggest that UCH-L3 promotes adipogenesis by enhancing insulin signaling in a hydrolase activity dependent manner.
19837878
ATM affects UCHL3
| 1
ATM activates UCHL3. 1 / 2
| 1
trips
Mechanistically, in response to DNA damage, the deubiquitinase UCHL3 is phosphorylated and activated by ATM.
27941124
Sirolimus affects UCHL3
| 2
Sirolimus increases the amount of UCHL3.
| 1
Sirolimus increases the amount of UCHL3. 1 / 1
| 1
reach
The aim of this study was to explore whether rapamycin can induce the autophagy of HL-60 cells and UCH-L3 expression.
30111405
Sirolimus activates UCHL3.
| 1
Sirolimus activates UCHL3. 1 / 1
| 1
reach
[Autophagy and Expression of UCH-L3 Induced by Rapamycin in HL-60 Cells].
30111405
Acetaldehyde affects UCHL3
| 2
Acetaldehyde inhibits UCHL3.
| 1
Acetaldehyde inhibits UCHL3. 1 / 1
| 1
reach
The present data demonstrated that ubiquitin aldehyde can inhibit the activity of UCHL3.
27780264
Acetaldehyde increases the amount of UCHL3.
| 1
Acetaldehyde increases the amount of UCHL3. 1 / 1
| 1
reach
Therefore, ubiquitin aldehyde may modulate the protein expression and function of UCHL3.
27780264
UCHL3 affects Ubiquitin
| 2
UCHL3 inhibits Ubiquitin.
| 1
UCHL3 inhibits Ubiquitin. 1 / 1
| 1
reach
Through application of a novel protein cleavage and tagging technique, sortagging, we show that human UCHL3 and the Plasmodium falciparum homologue, members of the ubiquitin C-terminal hydrolase family, use a unique active site crossover loop to restrict access of bulky ubiquitin adducts to the active site.
19047059
UCHL3 activates Ubiquitin.
| 1
UCHL3 activates Ubiquitin. 1 / 1
| 1
reach
The relevant control exerted by these DUBs on ubiquitin homeostasis may account for these effects since pharmacological blocking of UCHL1 or UCHL3 reduced the monomeric ubiquitin pool, in turn restricting the ubiquitination of GlyT2 in neurons (XREF_FIG).
23484054
Undecane affects UCHL3
1 |
Undecane decreases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
17337753
Trimellitic anhydride increases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
19042947
Trifluoperazine affects UCHL3
| 1
Trifluoperazine inhibits UCHL3. 1 / 1
| 1
reach
Pimozide, flupenthixol and trifluoperazine were poor inhibitors of UCH-L1 and UCH-L3 (IC 50> 500 muM).
22118673
Titanium dioxide affects UCHL3
1 |
Titanium dioxide increases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
30910687
Sodium arsenite affects UCHL3
1 |
Sodium arsenite increases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
29361514
Silicon dioxide affects UCHL3
1 |
Silicon dioxide decreases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
19073995
Senecionine affects UCHL3
1 |
Senecionine increases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
26100227
Sarin affects UCHL3
1 |
Sarin decreases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
19522546
Quercetin affects UCHL3
1 |
Quercetin decreases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
21632981
Prostaglandin J2 affects UCHL3
| 1
reach
Neither PGJ2 nor PGA1, D2, and E2 were found to inhibit UCH-L1 and UCH-L3.
15194490
Pimozide affects UCHL3
| 1
Pimozide inhibits UCHL3. 1 / 1
| 1
reach
Pimozide, flupenthixol and trifluoperazine were poor inhibitors of UCH-L1 and UCH-L3 (IC 50> 500 muM).
22118673
Phorbol 13-acetate 12-myristate increases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
25613284
Phlorizin affects UCHL3
1 |
Phlorizin decreases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
22538082
Paracetamol affects UCHL3
1 |
Paracetamol increases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
22230336
Microcystin affects UCHL3
1 |
Microcystin decreases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
22430071
Methylmercury chloride decreases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
23458150
Methapyrilene affects UCHL3
1 |
Methapyrilene increases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
30467583
Jinfukang affects UCHL3
1 |
Jinfukang decreases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
27392435
Ionomycin affects UCHL3
1 |
Ionomycin increases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
25613284
Hsa-miR-8082 affects UCHL3
1 |
Hsa-miR-8082 decreases the amount of UCHL3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
19536157
Hsa-miR-7156-5p affects UCHL3
1 |
Hsa-miR-7156-5p decreases the amount of UCHL3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
22012620
Hsa-miR-6781-3p affects UCHL3
1 |
Hsa-miR-6781-3p decreases the amount of UCHL3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
19536157
Hsa-miR-6507-3p affects UCHL3
1 |
Hsa-miR-6507-3p decreases the amount of UCHL3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
22012620
Hsa-miR-616-5p affects UCHL3
1 |
Hsa-miR-616-5p decreases the amount of UCHL3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
22012620
Hsa-miR-606 affects UCHL3
1 |
Hsa-miR-606 decreases the amount of UCHL3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
19536157
Hsa-miR-548p affects UCHL3
1 |
Hsa-miR-548p decreases the amount of UCHL3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
22012620
Hsa-miR-532-5p affects UCHL3
1 |
Hsa-miR-532-5p decreases the amount of UCHL3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
19536157
Hsa-miR-514b-5p affects UCHL3
1 |
Hsa-miR-514b-5p decreases the amount of UCHL3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
22012620
Hsa-miR-513c-5p affects UCHL3
1 |
Hsa-miR-513c-5p decreases the amount of UCHL3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
22012620
Hsa-miR-5093 affects UCHL3
1 |
Hsa-miR-5093 decreases the amount of UCHL3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
19536157
Hsa-miR-4633-5p affects UCHL3
1 |
Hsa-miR-4633-5p decreases the amount of UCHL3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
19536157
Hsa-miR-4534 affects UCHL3
1 |
Hsa-miR-4534 decreases the amount of UCHL3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
19536157
Hsa-miR-4273 affects UCHL3
1 |
Hsa-miR-4273 decreases the amount of UCHL3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
22012620
Hsa-miR-375 affects UCHL3
1 |
Hsa-miR-375 decreases the amount of UCHL3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
20215506
Hsa-miR-373-5p affects UCHL3
1 |
Hsa-miR-373-5p decreases the amount of UCHL3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
22012620
Hsa-miR-372-5p affects UCHL3
1 |
Hsa-miR-372-5p decreases the amount of UCHL3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
22012620
Hsa-miR-371b-5p affects UCHL3
1 |
Hsa-miR-371b-5p decreases the amount of UCHL3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
22012620
Hsa-miR-371a-5p affects UCHL3
1 |
Hsa-miR-371a-5p decreases the amount of UCHL3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
22012620
Hsa-miR-3688-3p affects UCHL3
1 |
Hsa-miR-3688-3p decreases the amount of UCHL3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
19536157
Hsa-miR-3134 affects UCHL3
1 |
Hsa-miR-3134 decreases the amount of UCHL3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
19536157
Hsa-miR-3124-3p affects UCHL3
1 |
Hsa-miR-3124-3p decreases the amount of UCHL3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
19536157
Hsa-miR-2682-3p affects UCHL3
1 |
Hsa-miR-2682-3p decreases the amount of UCHL3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
19536157
Hsa-miR-2117 affects UCHL3
1 |
Hsa-miR-2117 decreases the amount of UCHL3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
22012620
Hsa-miR-183-5p affects UCHL3
1 |
Hsa-miR-183-5p decreases the amount of UCHL3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
23622248
Hsa-miR-130b-5p affects UCHL3
1 |
Hsa-miR-130b-5p decreases the amount of UCHL3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
19536157
Hexabromocyclododecane decreases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
29177809
Gentamycin affects UCHL3
1 |
Gentamycin increases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
22061828
Endosulfan affects UCHL3
1 |
Endosulfan increases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
29391264
Electrophilic reagent inhibits UCHL3. 1 / 1
| 1
sparser
These endogenous electrophiles (1) inhibit ubiquitin isopeptidase activity [ xref ] as well as ubiquitin hydrolases UCH-L1 and UCH-L3 [ xref ], (2) induce the formation of cysteine-targeted thyolation of UCH-L1 [ xref ] and of PGJ2/proteasome conjugates [ xref ], (3) trigger the oxidation of the S6 ATPase subunit of the 26S proteasome [ xref ], and disrupt 26S proteasome assembly [ xref ].
19630993
Dorsomorphin affects UCHL3
1 |
Dorsomorphin increases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
27188386
Diuron affects UCHL3
1 |
Diuron increases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
21551480
Dicrotophos affects UCHL3
1 |
Dicrotophos decreases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
28302478
Dibutyl phthalate affects UCHL3
1 |
Dibutyl phthalate decreases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
17361019
Dibenzothiophene affects UCHL3
1 |
Dibenzothiophene decreases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
23656968
Diarsenic trioxide increases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
25419056
Copper(II) sulfate increases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
19549813
Chlorpyrifos affects UCHL3
1 |
Chlorpyrifos decreases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
18668222
Chalcone affects UCHL3
| 1
Chalcone inhibits UCHL3. 1 / 1
| 1
reach
RA-9, a chalcone derivative with a structure similar to b-AP15, was reported to inhibit proteasomal DUBs [XREF_BIBR] as well as UCHL1, UCHL3, USP2, USP5, and USP8 [XREF_BIBR].
29039082
Bisphenol A affects UCHL3
1 |
Bisphenol A increases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
25181051
Bis(2-ethylhexyl) phthalate increases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
19850644
Aldehyde affects UCHL3
| 1
Aldehyde inhibits UCHL3. 1 / 1
| 1
sparser
We found complex viscosity dependencies and interpreted these in the context of a model in which association and acylation are viscosity-dependent but deacylation is viscosity-independent. (2) The kinetics of inhibition of UCH-L3 by ubiquitin C-terminal aldehyde (Ub-H) were determined and reveal a Ki that is less than 10(-14) M. Several mechanisms are considered to account for the extreme inhibition. (3) The IPaseT-catalyzed hydrolysis of Ub-AMC is modulated by Ub with activation at low [Ub] and inhibition at high [Ub]. (4) Finally, we compare kc/Km values for deubiquitinating enzyme-catalyzed hydrolysis of Ub-AMC and Z-Leu-Arg-Gly-Gly-AMC.
9485312
Aflatoxin B1 affects UCHL3
1 |
Aflatoxin B1 increases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
27153756
ZIC1 affects UCHL3
1 |
ZIC1 decreases the amount of UCHL3. 1 / 1
1 |
biopax:msigdb
No evidence text available
UCHL5 affects UCHL3
| 1
UCHL5 activates UCHL3. 1 / 1
| 1
reach
Overexpression of UCH-L5 (but not overexpression of UCH-L3) for two days prior to the infection with Salmonella for one hour also lead to significant cell death (XREF_FIG), while cell treatment with b-AP15 inhibitor prior to Salmonella infection led to slight increase in cell viability in comparison to vehicle treated cells (XREF_SUPPLEMENTARY).
26267804
UCHL3 inhibits ubiquitin carboxyl-terminal hydrolase. 1 / 1
| 1
reach
The researchers were surprised to discover that their C-terminally propargylated Ub (Ub-Prg), originally synthesized for site specific ubiquitination of peptides, inhibited the human DUB ubiquitin carboxyl-terminal hydrolase isoenzyme L3 (UCHL3).
26933738
UCHL3 affects sodium atom
| 1
UCHL3 activates sodium atom. 1 / 1
| 1
reach
Whereas Usp10 has been implicated in removal of ubiquitin from CFTR during recycling [57], Usp33 and Usp20 have been proposed to remove ubiquitin from the recycling beta-adrenergic receptor [58] while[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
22800866
UCHL3 affects proteolysis
| 1
UCHL3 activates proteolysis. 1 / 1
| 1
reach
UCHL3 was responsible for the disassembly of the ubiquitin protein complex or polyubiquitin chains during the substrate priming for proteasomal proteolysis to prevent inappropriate protein degradation [XREF_BIBR].
27780264
UCHL3 affects localization
| 1
UCHL3 activates localization. 1 / 1
| 1
reach
Instead, UCHL3 promotes localization of Aurora B to kinetochores, suggesting its role in the error correction mechanism monitoring bi-orientation of chromosomes during metaphase.
32738097
UCHL3 activates glycolytic process. 1 / 1
| 1
reach
UCHL3 promotes aerobic glycolysis of pancreatic cancer through upregulating LDHA expression.
33616859
UCHL3 affects cell migration
| 1
reach
In highly metastatic prostate PC3 cells, UCH-L3 inhibits the cell migration and invasion but UCH-L3 C95S had no effects, suggesting that the hydrolase activity of UCH-L3 is required to inhibit the met[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
25194810
UCHL3 affects autophagy
| 1
UCHL3 activates autophagy. 1 / 1
| 1
reach
Taken together, the results of the present study suggest that UCHL3 knockdown decreases melanoma cell proliferation by increasing cell autophagy through regulating NEDD8 expression and autophagosome numbers.
34539860
UCHL3 affects apoptotic process
| 1
reach
Hence, loss of UCH-L3 leads to mitochondrial oxidative stress related photoreceptor cell apoptosis in a caspase independent manner.
16816367
UCHL3 affects ZRANB1
| 1
UCHL3 activates ZRANB1. 1 / 1
| 1
reach
Structure of a USP20 inhibitor from GSK.Figure 29 Structure of a USP30 inhibitor.Structures of UCHL1 inhibitors.VAE(OMe)-FMK Structure of a weak tripeptide FMK UCHL1 inhibitor.Figure 33 Structures of UCHL3 inhibitors.Structures of TRABID and RPN11 inhibitors.
26852935
UCHL3 affects UCHL5
| 1
UCHL3 increases the amount of UCHL5. 1 / 1
| 1
reach
This indicates that UCH-L5 protein levels are modulated by either a pathogen or a host, and only the activity of UCH-L3 is changed during infection with Salmonella, which could be caused by changes in post-translational modifications of this enzyme [XREF_BIBR].
26267804
UCHL3 affects UCHL3
| 1
Modified UCHL3 activates UCHL3. 1 / 1
| 1
reach
Moreover, ectopic expression of wild-type UCH-L3 restored the phosphorylation of insulin and IGF-I receptor and adipocyte differentiation in Uchl3 (-/-) MEFs.
19837878
UCHL3 affects UCH
| 1
UCHL3 activates UCH. 1 / 1
| 1
reach
This suggests that UCH functions associated with the egg cortex and oolemma may be at least partially restored by UCHL3 function, if opportunity for this is presented during oogenesis.
21678411
UCHL3 affects TYK2
| 1
UCHL3 increases the amount of TYK2. 1 / 1
| 1
reach
Interestingly, we found that UCHL3 overexpression upregulated p-TYK2 levels induced by IFNalpha.
28583475
UCHL3 affects TWIST1
| 1
UCHL3 inhibits TWIST1. 1 / 1
| 1
reach
We found that UCH-L3 knockdown in RWPE1 upregulates Snail, Slug, and Twist.
25194810
UCHL3 affects TRAF2
| 1
UCHL3 activates TRAF2. 1 / 1
| 1
reach
UCHL3 promotes ovarian cancer progression by stabilizing TRAF2 to activate the NF-kappaB pathway.
31477831
UCHL3 affects SOX12
| 1
UCHL3 activates SOX12. 1 / 1
| 1
reach
UCHL3 promotes proliferation of colorectal cancer cells by regulating SOX12 via AKT and mTOR signaling pathway.
33194042
UCHL3 affects SNAI2
| 1
UCHL3 inhibits SNAI2. 1 / 1
| 1
reach
We found that UCH-L3 knockdown in RWPE1 upregulates Snail, Slug, and Twist.
25194810
UCHL3 affects SNAI1
| 1
UCHL3 inhibits SNAI1. 1 / 1
| 1
reach
We found that UCH-L3 knockdown in RWPE1 upregulates Snail, Slug, and Twist.
25194810
UCHL3 affects SMAD1
| 1
UCHL3 bound to SMAD1 decreases the amount of ubiquitinated SMAD1. 1 / 1
| 1
reach
We found that Uch-L3 physically interacts with Smad1 and dramatically decreases the amount of poly-ubiquitinated Smad1.
21453705
UCHL3 affects Proteasome
| 1
UCHL3 inhibits Proteasome. 1 / 1
| 1
reach
Inhibiting the proteasome using MG132 led to marked enrichment of K48 ubiquitylated TDP1 in control cells but no impact in rhabdomyosarcoma cells, due to high UCHL3 levels (XREF_FIG C).
29898404
UCHL3 affects PPARG
| 1
UCHL3 activates PPARG. 1 / 1
| 1
reach
In addition, recombinant UCHL3 failed to deubiquitinate PPARgamma in vitro (XREF_SUPPLEMENTARY and XREF_SUPPLEMENTARY), indicating that UCHL3 modulates PPARgamma activity by an indirect mechanism, either through its ubiquitin hydrolase or its deneddylase activity.
22679485
reach
UCHL3 stimulates metastasis of gastric cancer through upregulating IGF2.
34278751
UCHL3 affects NFKBIA
| 1
UCHL3 increases the amount of NFKBIA. 1 / 1
| 1
reach
The results showed that UCHL3 upregulated protein levels of IkappaBalpha.
28583475
UCHL3 affects NEDD8
| 1
UCHL3 activates NEDD8. 1 / 1
| 1
reach
It was reported that UCHL3 enables to cleave the C-terminus of NEDD8, which is a ubiquitin like protein that exerts the function of Ub to be conjugated to a lysine residue of the substrate.
33585209
UCHL3 affects Melanoma
| 1
UCHL3 activates Melanoma. 1 / 1
| 1
reach
Taken together, the results of the present study suggest that UCHL3 knockdown decreases melanoma cell proliferation by increasing cell autophagy through regulating NEDD8 expression and autophagosome numbers.
34539860
UCHL3 affects LDHA
| 1
UCHL3 increases the amount of LDHA. 1 / 1
| 1
reach
Further investigations revealed that LDHA expression was promoted by UCHL3 and could be reduced by shFOXM1, and that low expressed LDHA partly reversed the inhibition of aerobic glycolysis induced by overexpressed UCHL3.
33616859
UCHL3 affects Interferon
| 1
UCHL3 activates Interferon. 1 / 1
| 1
reach
Given that we demonstrated that UCHL3 promoted activation of IFN signaling, we observed whether IFN-I could affect the interaction between UCHL3 and COPS5.
28583475
UCHL3 affects IFNAR2
| 1
UCHL3 activates IFNAR2. 1 / 1
| 1
reach
This finding suggests that UCHL3 could target either TYK2 itself or IFN-I receptors (IFNAR1 and IFNAR2), which are the direct proteins upstream of TYK2 as well as the first signaling proteins in IFN-I[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
28583475
UCHL3 affects HELLS
| 1
UCHL3 activates HELLS. 1 / 1
| 1
reach
GIAT4RA interfered with ubiquitin hydrolase Uchl3 mediated interaction and stabilization of LSH.
31417184
UCHL3 affects ENaC
| 1
UCHL3 activates ENaC. 1 / 1
| 1
reach
Whereas Usp10 has been implicated in removal of ubiquitin from CFTR during recycling [57], Usp33 and Usp20 have been proposed to remove ubiquitin from the recycling beta-adrenergic receptor [58] while[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
22800866
bel
However, mice homozygous for both UCH-L1 and UCH-L3 deletions die early due to dysphagia and display degeneration of the nucleus tractus solitarius and area postrema in addition to the degeneration of the gracile tract that is observed in GAD mice that only have a UCH-L1 deletion
14556719
UCHL3 affects DNA repair
| 1
UCHL3 activates DNA repair. 1 / 1
| 1
reach
Silencing UCHL3 enhances radio-sensitivity of non small cell lung cancer cells by inhibiting DNA repair.
34016790
UCHL3 affects DNA Damage
| 1
UCHL3 activates DNA Damage. 1 / 1
| 1
reach
UCHL3 enhanced the DNA damage repair mediated by radiotherapy and chemotherapy in cancer cells via binding to tyrosyl DNA phosphodiesterase 1 (TDP1), a chromosome breakage repair related enzyme, and mediating TDP1 deubiquitination [XREF_BIBR - XREF_BIBR].
32351584
UCHL3 affects Caspase
| 1
UCHL3 inhibits Caspase. 1 / 1
| 1
reach
Hence, loss of UCH-L3 leads to mitochondrial oxidative stress related photoreceptor cell apoptosis in a caspase independent manner.
16816367
UCHL3 affects AHR
| 1
UCHL3 activates AHR. 1 / 1
| 1
reach
UCHL3 increased AhR stability and the binding of AhR to the promoter regions of the " stemness " genes ATP binding cassette subfamily G member 2 (ABCG2), KLF4, and c-Myc.
32546741
TCF3 affects UCHL3
1 |
TCF3 decreases the amount of UCHL3. 1 / 1
1 |
biopax:msigdb
No evidence text available
Senkirkine affects UCHL3
1 |
Senkirkine increases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
26100227
SLC4A1 affects UCHL3
| 1
SLC4A1 inhibits UCHL3. 1 / 1
| 1
reach
Thus, we speculated that di-Ub might inhibit the enzymatic activity of UCH-L3.
19154770
PKA affects UCHL3
| 1
PKA activates UCHL3. 1 / 1
| 1
reach
UCH-L3, for example, is apparently stimulated by cAMP and PKA so as to enhance ENaC recycling.
20940433
PGA1 affects UCHL3
| 1
PGA1 inhibits UCHL3. 1 / 1
| 1
reach
Neither PGJ2 nor PGA1, D2, and E2 were found to inhibit UCH-L1 and UCH-L3.
15194490
PDIA6 affects UCHL3
| 1
PDIA6 inhibits UCHL3. 1 / 1
| 1
reach
However, it is also likely that the Arg at P5 in Ac-RLRGG-AFC negates the salt-dependent activation of UCH-L3, possibly because it is in contact with the mobile loop of the enzyme (Fig 3B) and thus serves a similar function to the salt effect.
18601651
NRF1 affects UCHL3
1 |
NRF1 decreases the amount of UCHL3. 1 / 1
1 |
biopax:msigdb
No evidence text available
N-nitrosodiethylamine decreases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
20360939
N-acetyl-beta-D-galactosaminyl-(1->4)-N-acetyl-D-glucosaminyl group inhibits UCHL3. 1 / 1
| 1
sparser
As LDN can also inhibit UCHL3, we determined the UCHL3 protein level in the sham group and MI group 14 days after operation and found that no significant differences between the two groups (Supplemental Fig.  xref ).
32606430
LEF1 affects UCHL3
1 |
LEF1 decreases the amount of UCHL3. 1 / 1
1 |
biopax:msigdb
No evidence text available
INS affects UCHL3
| 1
INS inhibits UCHL3. 1 / 1
| 1
reach
The phosphorylation of insulin and IGF-I receptor, Akt, glycogen synthase kinase-3beta, and FoxO1 was decreased in Uchl3 (-/-) MEFs treated with insulin.
19837878
ICG 001 affects UCHL3
1 |
ICG 001 decreases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
26191083
GSK-J4 affects UCHL3
1 |
GSK-J4 increases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
29301935
FOXJ2 affects UCHL3
1 |
FOXJ2 decreases the amount of UCHL3. 1 / 1
1 |
biopax:msigdb
No evidence text available
Environmental Pollutants increases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
20064776
EGR4 affects UCHL3
1 |
EGR4 decreases the amount of UCHL3. 1 / 1
1 |
biopax:msigdb
No evidence text available
EGR1 affects UCHL3
1 |
EGR1 decreases the amount of UCHL3. 1 / 1
1 |
biopax:msigdb
No evidence text available
E2 affects UCHL3
| 1
E2 inhibits UCHL3. 1 / 1
| 1
reach
Neither PGJ2 nor PGA1, D2, and E2 were found to inhibit UCH-L1 and UCH-L3.
15194490
DDT affects UCHL3
1 |
DDT increases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
30207508
COPS5 affects UCHL3
| 1
COPS5 activates UCHL3. 1 / 1
| 1
reach
However, we found that knockout of COPS5 abolished the effect of UCHL3 on Cullin1 deneddylation, indicating that COPS5 is required for UCHL3 mediated deneddylation of Cullin1 in cells.
28583475
CDH1 affects UCHL3
| 1
CDH1 inhibits UCHL3. 1 / 1
| 1
reach
As shown in Fig. 4 A, E-cadherin increased but vimentin decreased in UCH-L3 overexpressing PC3 cells compared to mock or vector control cells.
25194810
CANT1 affects UCHL3
| 1
CANT1 inhibits UCHL3. 1 / 1
| 1
reach
It appears therefore that SCAN1 cells downregulate UCHL3 in an attempt to avoid the unfavorable outcomes of accumulating further PDBs.
29898404
C646 compound affects UCHL3
1 |
C646 compound decreases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
26191083
2-hydroxypropanoic acid decreases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
30851411
sparser
Treatment with Δ 12 -PGJ 2 in cells also inhibited UCH-L1 and UCH-L3 without alteration of proteasomal activity, indicating that prostaglandins can be suitable for neural disorder therapy [ 95 ] .
| PMC
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione decreases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
26217789
1H-pyrazole affects UCHL3
1 |
1H-pyrazole increases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
17945193
15-deoxy-Delta(12,14)-prostaglandin J2 inhibits UCHL3. 1 / 1
| 1
reach
The inhibitory effect of prostaglandins is exemplified by 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) (Fig. 2, compound 4), which inhibits the activities of UCHL-3 (Ref.
22088887
1,2-dichloroethane decreases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
28960355
4,4'-sulfonyldiphenol increases the amount of UCHL3. 1 / 1
1 |
ctd
No evidence text available
27685785
3',5'-cyclic AMP affects UCHL3
| 1
reach
UCH-L3, for example, is apparently stimulated by cAMP and PKA so as to enhance ENaC recycling.
20940433